Your immune system is a security team. Its job is to spot intruders (bacteria, viruses, parasites) and take them out. In autoimmune disease, the security team gets confused and starts attacking the building it was hired to protect.

About 7.4 percent of men will be diagnosed with at least one autoimmune disease in their lifetime. That number is climbing. And here's the part nobody tells you: men have been sold a lie that autoimmune disease is a "woman's problem." It's not. Women get more autoimmune disease overall, about 2 to 1. But several of these conditions actually prefer men, many hit men harder when they strike, and the biggest risk men face is getting diagnosed years late because nobody was looking.

We catalogued 107 autoimmune diseases that affect men. The full reference is in the appendix at the bottom of this post. This article is the orientation. Read this first, then use the appendix to dig into anything that sounds like you.

A Short Note on What We're Doing Here

This is heavier material than most of what we cover. We're going to handle it without two failure modes: turning it into WebMD anxiety bait, or burying useful information under so much hedging that nobody learns anything.

If you finish this article recognizing yourself in something, that isn't a diagnosis. It's information. The next step is a real conversation with a real doctor. Bring the relevant entries from the appendix. Doctors appreciate that more than you'd think.

What an Autoimmune Disease Actually Is

Your immune system distinguishes self from non-self by checking ID badges on cells (proteins called antigens). Autoimmune disease happens when the system stops recognizing the badge and starts attacking your own tissues as if they were foreign invaders.

The attack can be focused (one organ) or systemic (multiple organs). It can come in waves (flares and remissions) or steadily grind on. It can be mild enough to ignore or aggressive enough to kill. And the same disease can show up completely differently in two different men.

That last part matters. Autoimmune disease does not read the textbook. The "classic presentation" is what the textbook shows. The actual presentation is whatever your body decides to do.

Why Men Get Autoimmune Disease

There's no single cause. It's a recipe: genes, hormones, environment, infections, and bad luck have to combine in just the wrong way.

Genetics

If autoimmune disease runs in your family, your risk goes up. Specific genes (like HLA-B27 in ankylosing spondylitis) can multiply risk dramatically. Identical twins share autoimmune diseases far more often than fraternal twins, which proves DNA is doing real work here.

Hormones

Testosterone is mostly anti-inflammatory and protective. This is one reason men get fewer autoimmune diseases than women. The plot twist: as testosterone declines with age, the risk of rheumatoid arthritis, lupus, MS, and Hashimoto's goes up. Men on androgen deprivation therapy for prostate cancer also face higher rheumatoid arthritis risk, and the longer the therapy, the higher the risk.

Environment

Smoking, Epstein-Barr virus infection, UV exposure, silica dust, organic solvents, and certain medications can all flip the autoimmune switch in someone who's genetically primed.

Vitamin D

Low vitamin D is consistently linked to higher rates of MS, lupus, type 1 diabetes, and inflammatory bowel disease. The VITAL study (over 25,000 adults followed for 5 years) found that 2,000 IU per day of vitamin D reduced autoimmune disease incidence by 22 percent. Omega-3 fatty acids added another 15 percent reduction. This is one of the cheapest, most evidence-backed interventions in medicine that nobody talks about.

Gut Health

The trillions of bacteria in your intestines play a surprisingly large role in immune regulation. Antibiotics, processed food, and chronic stress can disrupt the balance and contribute to autoimmune activation.

Medications

Some drugs can trigger autoimmunity directly. Procainamide causes drug-induced lupus in 15 to 20 percent of users. Hydralazine causes it in 7 to 13 percent. Checkpoint inhibitors used in cancer treatment can trigger almost any autoimmune disease. The good news: drug-induced autoimmunity usually resolves after stopping the drug.

The Diseases That Prefer Men

Most discussion of autoimmune disease assumes a female patient. These conditions break that pattern. They affect men more often, sometimes dramatically.

Ankylosing Spondylitis

Chronic inflammation of the spine and sacroiliac joints. Starts as low back pain before age 45 that improves with movement and worsens with rest (opposite of a disc problem). Average diagnostic delay is 7 to 10 years, partly because men attribute it to "old sports injuries." Key tests: HLA-B27, MRI of the SI joints. Treatment has been transformed by biologics. Exercise (especially swimming) is not optional.

Primary Sclerosing Cholangitis

Chronic scarring of the bile ducts. Affects men twice as often as women. Strongly tied to ulcerative colitis (80 percent of PSC patients have UC). If you have UC and your liver enzymes are climbing, get an MRCP.

IgG4-Related Disease

Painless organ swelling that mimics cancer. Predominantly affects men over 50. Often misdiagnosed as pancreatic cancer (leading to unnecessary surgery), lymphoma, or Sjögren's. Responds dramatically to steroids, which is itself diagnostic.

VEXAS Syndrome

Discovered in 2020. Caused by a mutation on the X chromosome, which is why it almost exclusively affects men over 50 (prevalence about 1 in 4,000). Bridges rheumatology and hematology: severe inflammation plus bone marrow failure plus blood clots. Often previously misdiagnosed as relapsing polychondritis, Sweet syndrome, or "unclassified autoinflammatory disease" for years before the right answer was found.

Inclusion Body Myositis

The most common acquired myopathy in men over 50. Asymmetric weakness of the quadriceps and finger flexors. Frequently misdiagnosed as polymyositis and treated with steroids for years without improvement. Steroids don't work for IBM. Exercise does.

Multifocal Motor Neuropathy

Asymmetric weakness in the arms without sensory loss. Almost three times more common in men. The critical misdiagnosis is ALS, which is devastating because MMN is treatable with IVIG and ALS is not. If you've been told you have ALS but have no upper motor neuron signs and no bulbar involvement, get a second opinion focused on conduction block on nerve conduction studies.

IgA Nephropathy

The most common cause of glomerulonephritis worldwide. More common in men. Classic sign: visible blood in the urine during or right after an upper respiratory infection. If that's happened to you, your doctor needs to know.

Goodpasture Syndrome

🚨 Antibodies attack the kidneys and lungs. Spikes in young men in their 20s and 30s. Smoking dramatically increases the lung involvement. Coughing up blood plus rapidly declining kidney function is a medical emergency.

Reactive Arthritis

Joint inflammation triggered by a GI or genitourinary infection (often Chlamydia, Salmonella, Shigella, or Campylobacter). More common in HLA-B27 positive men. The classic triad is arthritis, urethritis, and conjunctivitis. If you got asymmetric joint pain in your knees or ankles a few weeks after a stomach bug or new sexual partner, this is worth asking about.

The Diseases That Hit Men Harder

These affect men and women at similar rates, but men tend to get more aggressive disease, more complications, or longer diagnostic delays.

Systemic Lupus Erythematosus

Far more common in women, but men with lupus have more kidney disease, more seizures, and more cardiovascular complications. The average diagnostic delay is even longer in men because doctors don't think of lupus in a male patient. Any man with unexplained multi-system disease, joint pain, rash, and a positive ANA should be evaluated for lupus.

Multiple Sclerosis

Men with MS tend to have more progressive disease and worse outcomes than women. Early aggressive treatment matters more, not less, in men. Don't accept the "wait and see" approach if you're a man with newly diagnosed MS.

Dermatomyositis

Male sex, age over 40, and certain antibodies (anti-TIF1-gamma, anti-NXP2) dramatically raise the risk that the myositis is caused by an underlying cancer. Cancer screening at diagnosis is mandatory, not optional.

Type 1 Diabetes (LADA in Adults)

When type 1 diabetes appears in an adult, it often gets misdiagnosed as type 2. If you're a lean adult, your "type 2 diabetes" isn't responding to oral medications, and your weight is dropping, ask for GAD65 antibody testing. Sulfonylureas actively accelerate beta cell destruction in LADA and should be avoided.

How to Spot It in Yourself

Autoimmune disease often whispers before it shouts. The early symptoms are vague enough to dismiss: fatigue, brain fog, mild joint pain, weird rashes that come and go, "stress."

Here's a checklist worth running through. Think of it as AUTOIMMUNE:

• Aching joints with morning stiffness lasting more than 30 minutes

• Unexplained fatigue that doesn't improve with rest

• Tingling, numbness, or weakness in hands or feet

• Odd rashes, especially ones triggered by sunlight

• Inflammation markers elevated on routine blood work

• Mouth ulcers that keep coming back

• Muscle weakness, especially if it's getting worse

• Urinary changes (blood or foam in your urine)

• New dry eyes or dry mouth that won't go away

• Extreme sensitivity to cold in your fingers (turning white or blue)

Three or more of these is a conversation with a doctor. Not a panic, just a conversation.

How to Bring It Up With a Doctor

Most men sabotage this conversation in the first sentence. "I've been tired" gets nowhere. Here's a script that actually works.

"I've been having [specific symptom] for [specific duration]. It's not improving. It's affecting my [work, sleep, exercise, sex life, whatever specifically]. My family history includes [autoimmune disease, if applicable]. I'd like to understand whether this could be something autoimmune."

Specifics are what get taken seriously. "I'm tired" is easy to dismiss. "I've been falling asleep at my desk by 2 PM for three months even after eight hours of sleep" is not.

Keep a symptom diary for two weeks before the appointment. What symptoms, when, what makes them better or worse, how they affect your day. Five lines a day. Bring it printed. Doctors respond to data the way you'd respond to a well-prepared business case.

How to Talk to the People Around You

Autoimmune diseases are mostly invisible. You look fine. You feel terrible. The gap between what people see and what's happening creates a unique kind of friction.

A few moves that help:

• Be honest but concise. "My immune system thinks part of my body is the enemy. Some days are fine, some days are rough. If I cancel plans, it's not personal."

• Educate without lecturing. Pick one or two facts and let those land. "It's why I'm so tired even when I look okay" beats a TED talk about cytokine signaling.

• Ask for specific help. "Can you drive me to my infusion next Tuesday?" works. "I need more support" doesn't.

The Diagnostic Minefield

Autoimmune disease is misdiagnosed more than almost any other category of illness. The average delay from symptom onset to correct diagnosis is 4 to 5 years, and often longer in men. Here's where it goes wrong.

The "Men Don't Get That" Reflex

Most autoimmune diseases are more common in women, so doctors don't think of them in male patients. This is the biggest single reason for diagnostic delay in men.

Seronegative Disease

Up to 20 percent of patients have autoimmune disease without the expected antibodies. A negative ANA does not rule out lupus. A negative rheumatoid factor does not rule out RA. If the clinical picture fits, push for further testing or biopsy.

The ANA Trap

A positive ANA shows up in about 15 percent of healthy people. Ordering ANA without clinical suspicion leads to unnecessary anxiety, referrals, and testing. ANA should only be ordered when symptoms point toward connective tissue disease.

The "It's Just Stress" Dismissal

Fatigue, brain fog, and vague aches are the most common early symptoms of autoimmune disease. They're also the easiest symptoms to wave away as stress. If symptoms are persistent, progressive, or paired with any objective finding (rash, swelling, abnormal lab), they need real investigation.

Drug-Induced Autoimmunity

Always check the medication list. Checkpoint inhibitors, hydralazine, procainamide, statins, minocycline, and TNF inhibitors (paradoxically) can all trigger autoimmune disease.

The appendix at the bottom of this post includes a "common misdiagnoses" entry for every disease, plus a separate section on the 15 diagnostic confusion clusters: the specific groups of autoimmune diseases that get mistaken for each other and the lab tests, imaging, and biopsy findings that sort them out. If you suspect an autoimmune disease, that's the section to read before your appointment.

What Actually Treats Autoimmune Disease

Treatment for autoimmune disease has been transformed in the last 20 years. The era of "just take steroids forever and hope for the best" is over for most diseases. Here's the modern ladder.

Step 1: Symptom Control

NSAIDs, levothyroxine, insulin, topical steroids. These don't change the disease, they just manage what it's doing right now.

Step 2: Conventional Immunosuppressants

Methotrexate, hydroxychloroquine, azathioprine, mycophenolate, sulfasalazine. These actually modify the disease. Hydroxychloroquine in lupus is the most important example: it should be on every lupus patient unless there's a specific reason not to.

Step 3: Biologics

TNF inhibitors, IL-17 inhibitors, IL-23 inhibitors, B-cell depletion (rituximab), complement inhibitors (eculizumab), interferon receptor blockers (anifrolumab). These are targeted at specific immune molecules. They're expensive, but they've transformed outcomes in RA, psoriasis, IBD, MS, lupus, and more.

Step 4: JAK Inhibitors

Oral medications that block intracellular immune signaling. Effective across multiple diseases. Important safety considerations: increased risk of blood clots, cardiovascular events, and malignancy in older patients with cardiovascular risk factors.

Step 5: Rescue Therapies

IVIG, plasmapheresis, cyclophosphamide, autologous stem cell transplant. For severe or refractory disease.

The Frontier

CAR-T cell therapy (originally a cancer treatment) has produced drug-free remission in severe lupus. Tolerogenic therapies aim to retrain the immune system instead of suppressing it. Teplizumab can delay the onset of type 1 diabetes in at-risk individuals by about 2 years. The field is moving faster than it has in decades.

What You Can Do That Doesn't Require a Prescription

This is where most articles either undersell or oversell. Here's the actual evidence.

Exercise

The most underrated treatment in autoimmune disease. Regular moderate exercise lowers CRP, IL-6, and TNF-alpha (the inflammation markers your immune system is making). It improves fatigue, reduces depression, maintains joint mobility, and improves cardiovascular health. Aim for 150 minutes a week of moderate activity. Swimming is particularly good for AS and RA because it's low impact.

Sleep

Poor sleep increases inflammatory cytokines and worsens disease activity. Sleep apnea is common in men and undertreated. If your partner says you snore, get tested.

Diet

The Mediterranean diet has the strongest evidence for reducing inflammation. Less processed food, more vegetables, more fish, more olive oil. This isn't a magic cure, but it's a real ten to twenty percent improvement in disease activity in several conditions.

Vitamin D and Omega-3s

The VITAL study earned these their spot. 2,000 IU vitamin D plus omega-3s reduced autoimmune disease incidence by up to 30 percent over 5 years. If you already have autoimmune disease, the evidence for reducing flares is also reasonable.

Smoking Cessation

Smoking is a risk factor for RA, lupus, MS, Crohn's, Graves', and psoriasis. It also reduces the effectiveness of TNF inhibitors. Quitting is one of the single highest-leverage interventions you can make.

Stress Management

Chronic psychological stress activates the inflammation cascade. Mindfulness, CBT, and yoga have all shown measurable benefit in RA, IBD, MS, and psoriasis. This isn't woo. Stress is a measurable biological trigger.

Weight Management

Adipose tissue produces inflammatory cytokines. Weight loss improves disease activity in RA, psoriasis, psoriatic arthritis, lupus, and MS.

Drugs and Substances That Make Things Worse

Some everyday things actively worsen autoimmune disease:

• Alcohol worsens psoriasis and is dangerous combined with methotrexate (liver toxicity). It triggers IBD flares. It impairs immune regulation.

• NSAIDs can trigger IBD flares. Use carefully if you have Crohn's or UC.

• Fluoroquinolone antibiotics can worsen myasthenia gravis and trigger tendon problems.

• Beta-blockers can worsen myasthenia gravis, psoriasis, and Raynaud's.

• Anabolic steroids can worsen multiple autoimmune conditions and trigger flares.

• Cocaine can worsen Raynaud's and cause vasculitis that looks like GPA.

Can Autoimmune Disease Be Overcome?

Honest answer: depends on which disease and how soon you caught it.

Diseases That Can Resolve or Go Into Prolonged Remission

Guillain-Barré syndrome (most recover fully), drug-induced lupus (resolves after stopping the drug), Goodpasture syndrome (antibodies often disappear), Graves' (radioactive iodine or surgery permanently fixes the hyperthyroidism), some cases of autoimmune hemolytic anemia and ITP.

Diseases That Can Be Well-Controlled With Treatment

RA, lupus, MS, IBD, psoriasis, myasthenia gravis, type 1 diabetes. With modern biologics and small molecules, many patients live essentially normal lives.

Diseases That Remain Challenging

Systemic sclerosis (no treatment reverses the fibrosis), primary sclerosing cholangitis (no proven medical therapy), progressive MS, severe lupus nephritis, inclusion body myositis.

The single biggest predictor of outcome is how early treatment started. The window of opportunity in RA, lupus, MS, and many other autoimmune diseases is real. Delayed treatment means irreversible organ damage. This is why getting diagnosed matters so much more than most people realize.

A Word on the Emotional Side

Getting diagnosed with an autoimmune disease as a man comes with a particular kind of weight. Many of us tie our identity to physical strength, reliability, and independence. An autoimmune disease can feel like a betrayal by your own body.

A few things worth knowing:

• The grief is normal. Anger, denial, bargaining, depression, acceptance. These aren't just for terminal diagnoses. They apply to any chronic illness.

• The invisibility is real. You'll look fine to people who don't know. Some of them will say unhelpful things. Most of them mean well.

• Depression and anxiety are 2 to 3 times more common in people with autoimmune disease. They're not character flaws. They're common complications. Treat them like any other complication: with professional help.

• You're not alone in this. The Arthritis Foundation, Lupus Foundation of America, National MS Society, Crohn's and Colitis Foundation, American Diabetes Association, and many others offer support groups and resources specifically for men.

The Bottom Line

Autoimmune diseases in men are underdiagnosed, undertreated, and underappreciated. The biggest risk most men face isn't the disease itself. It's the years of being told nothing is wrong while damage accumulates.

Pay attention to your body. Take persistent symptoms seriously. Don't let "men don't get that" or "you're just stressed" be the final answer to a problem that won't go away. Bring data. Ask questions. Find a doctor who looks rather than dismisses.

Early diagnosis. Aggressive treatment. Healthy lifestyle. Mental health support. That's the formula. None of it is complicated. All of it requires showing up.

Your immune system doesn't care about your pride. Neither should you.

Stay sharp. Stay strong. Stay yours.

📅 The full catalog follows below as an appendix. All 107 autoimmune diseases that affect men, with clinical presentation, diagnostic approach, common misdiagnoses, treatment options, drugs and foods to avoid, and prognosis for each. The 15 diagnostic confusion clusters. The cancer screening protocols for paraneoplastic autoimmune disease. The diagnostic pearls. An organ-system index.

This article is for general education and isn't medical advice. If you recognize something in yourself, that's worth a conversation with a qualified clinician. Bring the relevant entries from the appendix.

Appendix: The Complete Catalog

This is the full reference. 107 autoimmune diseases that affect men, with the clinical presentation, diagnostic approach, common misdiagnoses, treatments, lifestyle factors, and prognosis for each. Plus the 15 diagnostic confusion clusters (the diseases that get mistaken for each other), the cancer screening protocols for the autoimmune diseases tied to malignancy, the diagnostic pearls (one-liners worth memorizing), and an organ-system index for navigation.

Use it the way you'd use a reference book. Read the orientation above, then come back here when you want to look something up.

Index by Organ System

Quick navigator — find the cluster relevant to your symptoms, then look up the numbered diseases in the catalog below.

Joints and Spine. 1-Ankylosing Spondylitis, 6-Rheumatoid Arthritis, 22-Polymyalgia Rheumatica, 40-Mixed CTD, 93-Reactive Arthritis, 100-Psoriatic Arthritis

Endocrine. 2-Type 1 Diabetes, 9-Graves' Disease, 10-Hashimoto's, 16-Addison's Disease, 39-Autoimmune Polyendocrine Syndromes, 56-Autoimmune Hypophysitis, 83-Autoimmune Hypoparathyroidism, 105-LADA

Neuromuscular. 3-Myasthenia Gravis, 24-Guillain-Barre, 28-Dermatomyositis/Polymyositis, 35-CIDP, 37-Stiff Person Syndrome, 57-Lambert-Eaton, 66-Inclusion Body Myositis, 74-Multifocal Motor Neuropathy, 75-Anti-MAG Neuropathy, 87-IMNM, 88-Antisynthetase Syndrome

Central Nervous System. 7-Multiple Sclerosis, 32-Autoimmune Encephalitis (NMDAR/LGI1/CASPR2), 38-NMOSD, 51-Susac Syndrome, 63-Paraneoplastic Cerebellar Degeneration, 89-Rasmussen Encephalitis, 90-Opsoclonus-Myoclonus, 94-Anti-IgLON5 Disease, 95-MOGAD, 106-Bickerstaff Brainstem Encephalitis, 107-Autoimmune GFAP Astrocytopathy

Gastrointestinal. 4-IBD (Crohn's/UC), 11-Celiac Disease, 23-Autoimmune Pancreatitis, 59-Microscopic Colitis, 78-Autoimmune Atrophic Gastritis, 103-Autoimmune Enteropathy

Skin. 5-Psoriasis, 21-Vitiligo, 29-Alopecia Areata, 69-Morphea, 70-Lichen Sclerosus, 71-Lichen Planus

Blistering Diseases. 25-Pemphigus Vulgaris, 43-Bullous Pemphigoid, 44-Epidermolysis Bullosa Acquisita, 45-Linear IgA Bullous Dermatosis, 72-Pemphigus Foliaceus, 73-Mucous Membrane Pemphigoid, 85-Dermatitis Herpetiformis, 86-Paraneoplastic Pemphigus

Kidney. 14-Goodpasture Syndrome, 26-IgA Nephropathy, 42-Membranous Nephropathy, 82-C3 Glomerulopathy

Blood. 12-Pernicious Anemia, 17-Autoimmune Hemolytic Anemia, 33-ITP, 54-Evans Syndrome, 55-TTP, 60-Cold Agglutinin Disease, 65-Autoimmune Neutropenia, 77-PNH, 91-Acquired Hemophilia A, 92-Autoimmune Pure Red Cell Aplasia

Vascular (Vasculitis). 13-Vasculitis (GPA/MPA/PAN/Behcet's/GCA), 27-Antiphospholipid Syndrome, 46-EGPA, 47-Takayasu Arteritis, 99-HUVS, 102-IgA Vasculitis, 101-Kawasaki Disease

Liver and Biliary. 15-Autoimmune Hepatitis, 18-Primary Biliary Cholangitis, 30-Primary Sclerosing Cholangitis

Eyes and Ears. 49-VKH, 50-Cogan Syndrome, 52-Autoimmune Inner Ear Disease, 53-Autoimmune Retinopathy, 79-Sympathetic Ophthalmia, 80-Mooren Ulcer

Cardiac. 36-Autoimmune Myocarditis, 98-Dressler Syndrome

Autonomic. 58-Autoimmune Autonomic Ganglionopathy

Systemic / Multi-Organ. 8-SLE, 19-Sjogren's, 20-Systemic Sclerosis, 34-Sarcoidosis, 41-IgG4-Related Disease, 48-Relapsing Polychondritis, 61-Schnitzler Syndrome, 62-VEXAS Syndrome, 64-Idiopathic Multicentric Castleman Disease, 67-Adult-Onset Still's Disease, 76-POEMS Syndrome, 81-Eosinophilic Fasciitis

Reproductive. 31-Autoimmune Orchitis, 68-Paraneoplastic Syndromes (Testicular)

Lung. 96-Autoimmune Pulmonary Alveolar Proteinosis

Pediatric / Genetic. 84-IPEX Syndrome, 97-ALPS, 101-Kawasaki Disease, 104-Acute Rheumatic Fever

Diseases That PREFER Men. 1-Ankylosing Spondylitis, 26-IgA Nephropathy, 30-Primary Sclerosing Cholangitis (2:1), 41-IgG4-Related Disease, 48-Relapsing Polychondritis (overlap), 62-VEXAS Syndrome (X-linked, M>>F), 66-Inclusion Body Myositis (3:1), 69-Morphea (some forms), 74-Multifocal Motor Neuropathy (2.6:1), 81-Eosinophilic Fasciitis (~70%), 84-IPEX Syndrome (X-linked), 85-Dermatitis Herpetiformis (2:1), 93-Reactive Arthritis, 96-Autoimmune Pulmonary Alveolar Proteinosis (2:1), 101-Kawasaki Disease (1.5:1), 107-GFAP Astrocytopathy (55% male)

Diagnostic Pearls

If you only remember one line per category, make it this one.

Joints. Morning stiffness >30 min = inflammatory; DIP involvement = PsA; HLA-B27 + young man + back pain = AS

Liver. Hepatocellular + responds to steroids = AIH; cholestatic + AMA = PBC; cholestatic + UC + MRCP strictures = PSC

Demyelinating CNS. Central vein sign = MS; longitudinally extensive myelitis + AQP4 = NMOSD; bilateral ON with recovery = MOGAD; linear perivascular radial enhancement = GFAP

Cytopenias. Schistocytes = TTP emergency; positive Coombs = AIHA; isolated low platelets + no hemolysis = ITP

Thyroid. TRAb positive = Graves'; low RAIU = Hashitoxicosis (self-limited, no methimazole needed)

Blistering. Flaccid blisters + Nikolsky+ = pemphigus; tense blisters + intense itch in elderly = BP; grouped vesicles + celiac = DH

Vasculitis. PR3/c-ANCA + upper airway destruction = GPA; MPO/p-ANCA without granulomas = MPA; asthma + eosinophilia = EGPA

NMJ. Ptosis first = MG; proximal leg weakness first + diminished reflexes = LEMS

CTD. Anti-dsDNA + low complement = SLE; dry eyes/mouth + anti-SSA = Sjogren's; skin thickening + Raynaud's = scleroderma

Endocrine. Hyperpigmentation + hyponatremia + hyperkalemia = Addison's; lean type 2 diabetes failing oral meds = check GAD65 (LADA)

Myopathies. Asymmetric quadriceps + finger flexor weakness in man over 50 = IBM; very high CK + rapid onset = IMNM; skin rash = DM; ILD + mechanic's hands = antisynthetase

Encephalitis. Psychosis + seizures + dyskinesias in young adult = NMDAR; FBDS + hyponatremia in older man = LGI1; peripheral nerve hyperexcitability + insomnia = CASPR2; progressive sleep disorder + bulbar = anti-IgLON5

IgG4-RD. Multi-organ mass lesions + elevated IgG4 + storiform fibrosis = IgG4-RD; but always biopsy (IgG4 elevation alone is not diagnostic)

Sarcoidosis. Non-necrotizing granulomas + bilateral hilar LAD + exclusion of TB/lymphoma/fungal = sarcoidosis; Löfgren syndrome is virtually diagnostic

Kidney. Linear IgG on IF = Goodpasture (emergency); pauci-immune = ANCA-GN; full house = lupus; dominant IgA = IgA nephropathy; C3 dominant = C3G

Cancer screen. Refractory autoimmune disease = re-screen for occult malignancy; DM in men over 40 = mandatory cancer screen; LEMS in smoker = SCLC until proven otherwise

Universal. Drug-induced autoimmunity resolves after stopping drug; checkpoint inhibitors can trigger almost any autoimmune disease; men's diagnostic delays exceed women's by years for almost every autoimmune disease

The 107 Diseases

Each entry follows the same format: what the disease is, how it presents, how it's diagnosed, what it gets mistaken for, how to avoid those mistakes, medical treatment, lifestyle treatment, drugs that worsen it, food effects, harms to self, harms to others, and prognosis.

1. Ankylosing Spondylitis

• What it is. Chronic inflammatory disease primarily attacking the spine and sacroiliac joints; new bone formation can fuse the spine over time.

• Clinical presentation. Dull, deep low back pain starting before age 45; morning stiffness over 30 minutes that improves with movement and worsens with rest; pain that wakes in the second half of the night; chest pain from rib joint inflammation; iritis/uveitis in up to 40%; heel pain from Achilles enthesitis.

• How to diagnose. HLA-B27 (positive in ~90%); MRI of sacroiliac joints (detects inflammation years before X-ray changes); CRP/ESR; ASAS classification criteria.

• Common misdiagnoses. Mechanical back pain, disc herniation, sports injury, cardiac disease (chest pain), fibromyalgia.

• How to prevent diagnostic errors. Back pain that IMPROVES with exercise (not rest) is inflammatory; check HLA-B27 and MRI SI joints; average diagnostic delay is 7-10 years.

• Medical treatment. NSAIDs (first line, genuinely disease-modifying); TNF inhibitors (adalimumab, etanercept, infliximab); IL-17 inhibitors (secukinumab, ixekizumab); JAK inhibitors (tofacitinib, upadacitinib).

• Natural/lifestyle treatment. Daily exercise (especially swimming); physical therapy; smoking cessation; vitamin D; anti-inflammatory diet.

• Drugs that worsen. Long-term NSAID overuse risks (kidney, GI); biologics increase infection risk.

• Food effects. Mediterranean diet helps; smoking worsens disease and treatment response.

• Harms to self. Spinal fusion, uveitis (vision loss if untreated), cardiovascular disease, osteoporosis, restrictive lung disease.

• Harms to others. Genetic susceptibility passed to children (HLA-B27).

• Can it be overcome? Manageable but not curable; biologics can halt progression when started early.

2. Type 1 Diabetes

• What it is. Autoimmune destruction of insulin-producing pancreatic beta cells causing absolute insulin deficiency.

• Clinical presentation. Excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision; can present as diabetic ketoacidosis (nausea, vomiting, fruity breath, confusion).

• How to diagnose. Blood glucose, HbA1c, autoantibodies (GAD65, IA-2, ZnT8, insulin autoantibodies), C-peptide (low or absent).

• Common misdiagnoses. Type 2 diabetes (especially LADA in adults), stress hyperglycemia, steroid-induced diabetes, MODY.

• How to prevent diagnostic errors. If a lean adult fails oral diabetes meds, check autoantibodies; low C-peptide confirms T1D.

• Medical treatment. Insulin (no alternative); continuous glucose monitors; insulin pumps; carbohydrate counting; teplizumab to delay onset in at-risk individuals.

• Natural/lifestyle treatment. Exercise; carb counting; stress management. No herb, supplement, or diet replaces insulin.

• Drugs that worsen. Corticosteroids raise glucose; checkpoint inhibitors can trigger new-onset T1D.

• Food effects. Low glycemic index foods help control; refined carbs worsen.

• Harms to self. DKA, retinopathy, nephropathy, neuropathy, cardiovascular disease, hypoglycemia.

• Harms to others. Genetic susceptibility to children.

• Can it be overcome? Not curable; excellent control possible with modern technology.

3. Myasthenia Gravis

• What it is. Antibodies attack the neuromuscular junction causing fatigable muscle weakness that worsens with use and improves with rest.

• Clinical presentation. Drooping eyelids (ptosis), double vision, difficulty swallowing, slurred speech, limb weakness that worsens through the day; myasthenic crisis (respiratory failure) in severe cases.

• How to diagnose. Anti-AChR antibodies (~85%), anti-MuSK antibodies (some seronegative), repetitive nerve stimulation (decrement), CT chest for thymoma (20%).

• Common misdiagnoses. Chronic fatigue syndrome, depression, stroke, ALS, Lambert-Eaton syndrome.

• How to prevent diagnostic errors. Fluctuating weakness worse at end of day is the hallmark; ice pack test for ptosis; always do CT chest for thymoma.

• Medical treatment. Pyridostigmine; prednisone; azathioprine; mycophenolate; thymectomy; eculizumab or ravulizumab; IVIG/plasmapheresis for crisis.

• Natural/lifestyle treatment. Stress management; adequate rest; avoid heat; energy conservation.

• Drugs that worsen. Aminoglycosides, fluoroquinolones, beta-blockers, IV magnesium, botulinum toxin, certain anesthetics.

• Food effects. No specific food triggers.

• Harms to self. Myasthenic crisis (respiratory failure), aspiration pneumonia, falls.

• Harms to others. None directly.

• Can it be overcome? Most achieve good control; many achieve remission after thymectomy.

4. Inflammatory Bowel Disease (Crohn's and Ulcerative Colitis)

• What it is. Chronic GI tract inflammation; Crohn's affects any segment mouth-to-anus; UC affects colon and rectum only.

• Clinical presentation. Chronic diarrhea (often bloody in UC), abdominal pain, weight loss, fatigue, fever; Crohn's causes fistulas, abscesses, obstruction; extra-intestinal involvement (joints, eyes, skin, liver).

• How to diagnose. Colonoscopy with biopsies, stool calprotectin, CRP/ESR, CT/MR enterography for Crohn's.

• Common misdiagnoses. IBS, infectious colitis, celiac disease, colorectal cancer, diverticulitis.

• How to prevent diagnostic errors. IBS does NOT cause bloody stool, weight loss, fever, or elevated inflammatory markers; biopsy is essential.

• Medical treatment. 5-ASA (UC); corticosteroids (short-term); azathioprine; methotrexate; biologics (infliximab, adalimumab, vedolizumab, ustekinumab); JAK inhibitors; surgery for complications.

• Natural/lifestyle treatment. Mediterranean diet; omega-3; probiotics (VSL#3 for UC); smoking cessation (Crohn's); stress management.

• Drugs that worsen. NSAIDs trigger flares; antibiotics cause dysbiosis.

• Food effects. Fiber helps maintenance; processed foods and alcohol worsen.

• Harms to self. Colon cancer, strictures, fistulas, malnutrition, osteoporosis.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Well-controlled with biologics; some achieve mucosal healing.

5. Psoriasis

• What it is. Immune-driven overproduction of skin cells creating thick, scaly plaques.

• Clinical presentation. Silvery-scaled plaques on elbows, knees, scalp, lower back; nail pitting and onycholysis; psoriatic arthritis in up to 30%; genital psoriasis often underreported in men.

• How to diagnose. Clinical appearance; skin biopsy if uncertain; screen for psoriatic arthritis with joint symptoms.

• Common misdiagnoses. Eczema, fungal infection, seborrheic dermatitis, lichen planus, cutaneous lupus.

• How to prevent diagnostic errors. Well-demarcated silvery plaques with Auspitz sign; check nails and joints.

• Medical treatment. Topical steroids; vitamin D analogs; phototherapy; methotrexate; biologics (TNF, IL-17, IL-23 inhibitors); apremilast.

• Natural/lifestyle treatment. Mediterranean diet; weight loss; smoking cessation; moderate sun exposure; stress management.

• Drugs that worsen. Lithium, beta-blockers, antimalarials, alcohol (worsens and complicates methotrexate use).

• Food effects. Omega-3 helps; alcohol and processed foods worsen.

• Harms to self. Cardiovascular disease, metabolic syndrome, depression, psoriatic arthritis.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Near-complete clearance possible with modern biologics.

6. Rheumatoid Arthritis

• What it is. Chronic synovial inflammation causing progressive joint destruction.

• Clinical presentation. Symmetric small joint swelling (hands, feet), morning stiffness over 30 minutes, fatigue, rheumatoid nodules; can affect lungs, eyes, cardiovascular system.

• How to diagnose. RF, anti-CCP (more specific), CRP/ESR, joint X-ray/ultrasound; 2010 ACR/EULAR criteria.

• Common misdiagnoses. Osteoarthritis, gout, viral arthritis, fibromyalgia, sports injury.

• How to prevent diagnostic errors. RA causes swelling and prolonged morning stiffness; OA causes bony enlargement and brief stiffness.

• Medical treatment. Methotrexate (cornerstone, with folic acid); hydroxychloroquine; sulfasalazine; leflunomide; biologics; JAK inhibitors; short-term glucocorticoids.

• Natural/lifestyle treatment. Exercise; Mediterranean diet; omega-3; smoking cessation; weight management.

• Drugs that worsen. Smoking worsens disease and reduces TNF inhibitor effectiveness.

• Food effects. Omega-3 helps; excessive alcohol risks methotrexate liver toxicity.

• Harms to self. Joint destruction, cardiovascular disease, lung disease, osteoporosis, lymphoma (slight increase).

• Harms to others. Genetic susceptibility.

• Can it be overcome? Remission achievable with early aggressive treatment.

7. Multiple Sclerosis

• What it is. Immune attack on CNS myelin causing demyelination of brain and spinal cord nerve fibers.

• Clinical presentation. Optic neuritis, numbness/tingling, weakness, balance problems, bladder dysfunction, fatigue, cognitive fog; men tend to have more progressive disease.

• How to diagnose. MRI brain/spine (white matter lesions), lumbar puncture (oligoclonal bands), evoked potentials; McDonald criteria.

• Common misdiagnoses. Migraine, small vessel disease, NMOSD, vitamin B12 deficiency, neurosarcoidosis, MOGAD.

• How to prevent diagnostic errors. Lesions disseminated in time and space on MRI; test for AQP4 antibodies to exclude NMOSD before starting MS therapy.

• Medical treatment. Disease-modifying therapies (ocrelizumab, natalizumab, cladribine, fingolimod, interferons, dimethyl fumarate); symptom management.

• Natural/lifestyle treatment. Exercise; vitamin D (2000-4000 IU/day); smoking cessation; stress management; adequate sleep.

• Drugs that worsen. Checkpoint inhibitors; MS drugs are contraindicated if NMOSD.

• Food effects. Vitamin D-rich foods help; smoking worsens course.

• Harms to self. Disability progression, cognitive decline, depression, bladder dysfunction.

• Harms to others. Genetic susceptibility.

• Can it be overcome? High-efficacy DMTs prevent relapses; progressive MS harder to treat.

8. Systemic Lupus Erythematosus (SLE)

• What it is. Systemic autoimmune disease attacking multiple organs; more severe in men.

• Clinical presentation. Fatigue, joint pain, malar rash, mouth ulcers, photosensitivity, nephritis, serositis, cytopenias; men have more nephritis, seizures, cardiovascular events.

• How to diagnose. ANA, anti-dsDNA, anti-Smith, complement (C3/C4), urinalysis, CBC; 2019 EULAR/ACR criteria.

• Common misdiagnoses. Fibromyalgia, RA, viral infection, drug-induced lupus, vasculitis, lymphoma.

• How to prevent diagnostic errors. Men with multi-system disease + positive ANA need evaluation; diagnostic delay is longer in men.

• Medical treatment. Hydroxychloroquine (all patients); corticosteroids; mycophenolate; cyclophosphamide; belimumab; anifrolumab; voclosporin for nephritis.

• Natural/lifestyle treatment. Sun protection (SPF 50+); exercise; Mediterranean diet; stress management; vitamin D.

• Drugs that worsen. Procainamide, hydralazine (drug-induced lupus); UV light; sulfonamides; checkpoint inhibitors.

• Food effects. Sun avoidance critical; alfalfa sprouts may trigger flares.

• Harms to self. Nephritis, cardiovascular disease, stroke, infections, osteoporosis from steroids.

• Harms to others. Genetic susceptibility; neonatal lupus with anti-Ro antibodies.

• Can it be overcome? Many live normal lives with treatment; severe nephritis can still progress.

9. Graves' Disease

• What it is. Autoantibodies stimulate the thyroid to overproduce thyroid hormone (autoimmune hyperthyroidism).

• Clinical presentation. Weight loss with increased appetite, tachycardia, tremor, heat intolerance, anxiety, bulging eyes (ophthalmopathy), goiter.

• How to diagnose. TSH (suppressed), free T4/T3 (elevated), TSI/TRAb (positive), radioactive iodine uptake (high).

• Common misdiagnoses. Anxiety disorder, panic attacks, cardiac arrhythmia, pheochromocytoma, thyroiditis (Hashitoxicosis).

• How to prevent diagnostic errors. Check TSH in any man with unexplained anxiety, weight loss, or new-onset atrial fibrillation; TRAb distinguishes Graves' from Hashitoxicosis.

• Medical treatment. Methimazole; radioactive iodine; thyroidectomy; beta-blockers for symptoms.

• Natural/lifestyle treatment. Stress management; smoking cessation (worsens ophthalmopathy); selenium for mild eye disease.

• Drugs that worsen. Amiodarone, iodine-containing contrast, checkpoint inhibitors.

• Food effects. Iodine excess worsens; cruciferous vegetables may mildly reduce thyroid hormone.

• Harms to self. Atrial fibrillation, heart failure, thyroid storm, osteoporosis, ophthalmopathy.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Curable with RAI or surgery (then lifelong thyroid replacement).

10. Hashimoto's Thyroiditis

• What it is. Immune destruction of the thyroid gland causing hypothyroidism.

• Clinical presentation. Fatigue, weight gain, cold intolerance, constipation, dry skin, depression, brain fog, bradycardia, hair loss.

• How to diagnose. TSH (elevated), free T4 (low), anti-TPO antibodies, anti-thyroglobulin antibodies.

• Common misdiagnoses. Depression, aging, low testosterone, chronic fatigue, iron deficiency.

• How to prevent diagnostic errors. Simple TSH test clarifies; in men, symptoms often blamed on aging or depression.

• Medical treatment. Levothyroxine (empty stomach, 30-60 min before breakfast); dose adjusted by TSH.

• Natural/lifestyle treatment. Selenium (200 mcg/day may reduce antibodies); adequate iodine; exercise; stress management.

• Drugs that worsen. Lithium, amiodarone, checkpoint inhibitors, interferon-alpha.

• Food effects. Calcium, iron, soy, coffee interfere with levothyroxine absorption.

• Harms to self. Myxedema coma (rare), cardiovascular disease, depression, infertility.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Easily managed with levothyroxine; not reversible but rarely needs to be.

11. Celiac Disease

• What it is. Immune reaction to gluten that damages the small intestine lining.

• Clinical presentation. Diarrhea, bloating, weight loss, fatigue, iron deficiency anemia, osteoporosis, dermatitis herpetiformis, neuropathy; some men have only extra-intestinal symptoms.

• How to diagnose. tTG-IgA, total IgA, small bowel biopsy (gold standard); patient must be eating gluten during testing.

• Common misdiagnoses. IBS, lactose intolerance, anxiety, iron deficiency anemia (other causes), wheat allergy.

• How to prevent diagnostic errors. Men diagnosed less often; any unexplained iron deficiency or osteoporosis should prompt testing.

• Medical treatment. Strict lifelong gluten-free diet; no medication replaces dietary avoidance.

• Natural/lifestyle treatment. Gluten-free diet; nutritional supplementation (iron, calcium, vitamin D, B12, folate).

• Drugs that worsen. None specific.

• Food effects. Gluten must be strictly avoided; oats usually safe.

• Harms to self. Intestinal lymphoma, osteoporosis, infertility, neuropathy.

• Harms to others. Genetic susceptibility (HLA-DQ2/DQ8).

• Can it be overcome? Excellent prognosis with strict gluten-free diet; intestinal healing occurs.

12. Pernicious Anemia

• What it is. Autoimmune destruction of stomach parietal cells and intrinsic factor causing vitamin B12 deficiency.

• Clinical presentation. Fatigue, pallor, glossitis, numbness/tingling, balance problems, cognitive changes, macrocytic anemia.

• How to diagnose. CBC (macrocytic anemia), low B12, elevated MMA/homocysteine, anti-IF antibodies, anti-parietal cell antibodies.

• Common misdiagnoses. Dietary B12 deficiency, alcoholism, folate deficiency, hypothyroidism, MDS.

• How to prevent diagnostic errors. If B12 is low on a normal diet, test for pernicious anemia; neurological symptoms can precede anemia.

• Medical treatment. B12 injections (IM) or high-dose oral B12 (1000-2000 mcg/day).

• Natural/lifestyle treatment. B12-rich foods (meat, fish, dairy); oral supplementation works via passive diffusion.

• Drugs that worsen. Metformin reduces B12 absorption; PPIs reduce acid-dependent B12 release.

• Food effects. B12-rich foods help; strict vegan diet worsens.

• Harms to self. Subacute combined degeneration of spinal cord, dementia, increased gastric cancer risk.

• Harms to others. None directly.

• Can it be overcome? Manageable with lifelong B12 supplementation.

13. Vasculitis (GPA, MPA, PAN, Behcet's, GCA)

• What it is. Group of diseases with blood vessel inflammation; multiple types affect men differently.

• Clinical presentation. GPA: sinusitis, hemoptysis, kidney failure. PAN: testicular pain, neuropathy. Behcet's: oral/genital ulcers, uveitis. GCA: headache, jaw claudication, vision loss.

• How to diagnose. ANCA (c-ANCA/PR3 for GPA, p-ANCA/MPO for MPA), biopsy, angiography, ESR/CRP.

• Common misdiagnoses. Infection, malignancy, drug reaction, sarcoidosis, IgG4-RD.

• How to prevent diagnostic errors. Testicular pain in PAN is a clue in men; temporal headache + jaw claudication = GCA emergency.

• Medical treatment. Corticosteroids; cyclophosphamide; rituximab; methotrexate; azathioprine; plasma exchange for severe disease.

• Natural/lifestyle treatment. Smoking cessation; exercise; anti-inflammatory diet.

• Drugs that worsen. Cocaine (mimics GPA), hydralazine (ANCA-positive vasculitis).

• Food effects. Anti-inflammatory diet helps.

• Harms to self. Organ damage (kidneys, lungs, eyes), stroke, blindness (GCA), aneurysm.

• Harms to others. None directly.

• Can it be overcome? Variable; GPA/MPA can achieve remission; Behcet's chronic; GCA usually self-limited.

14. Goodpasture Syndrome (Anti-GBM Disease)

• What it is. Anti-GBM antibodies attack kidney and lung basement membranes; more common in young men.

• Clinical presentation. Hemoptysis, rapidly progressive kidney failure, fatigue, dyspnea; smoking dramatically increases lung involvement.

• How to diagnose. Anti-GBM antibodies, kidney biopsy (linear IgG), chest imaging.

• Common misdiagnoses. Pneumonia, pulmonary embolism, GPA, lupus nephritis, IgA nephropathy.

• How to prevent diagnostic errors. Rapidly progressive glomerulonephritis + hemoptysis = anti-GBM until proven otherwise; always check anti-GBM AND ANCA.

• Medical treatment. Plasmapheresis (emergency); high-dose corticosteroids; cyclophosphamide.

• Natural/lifestyle treatment. Smoking cessation (critical); avoid hydrocarbon exposure.

• Drugs that worsen. Smoking dramatically worsens lung involvement.

• Food effects. No specific food effects.

• Harms to self. End-stage kidney disease, pulmonary hemorrhage, death if untreated.

• Harms to others. None directly.

• Can it be overcome? Antibodies usually disappear after treatment; recurrence rare.

15. Autoimmune Hepatitis

• What it is. Immune attack on the liver causing hepatitis and potentially cirrhosis.

• Clinical presentation. Fatigue, abdominal pain, jaundice, joint pain, nausea; one-third have cirrhosis at diagnosis.

• How to diagnose. Elevated AST/ALT, elevated IgG, ANA, anti-SMA, anti-LKM-1, liver biopsy.

• Common misdiagnoses. Alcoholic liver disease, NAFLD, viral hepatitis, drug-induced liver injury, Wilson's disease.

• How to prevent diagnostic errors. If liver enzymes elevated and patient doesn't drink heavily, consider AIH; check IgG and autoantibodies.

• Medical treatment. Prednisone + azathioprine; budesonide for non-cirrhotic patients.

• Natural/lifestyle treatment. Avoid alcohol; maintain healthy weight; exercise.

• Drugs that worsen. Nitrofurantoin, minocycline, statins, checkpoint inhibitors, some herbal supplements.

• Food effects. Avoid alcohol; coffee may be hepatoprotective.

• Harms to self. Cirrhosis, liver failure, hepatocellular carcinoma, osteoporosis from steroids.

• Harms to others. None directly.

• Can it be overcome? Most require long-term immunosuppression; some achieve sustained remission.

16. Addison's Disease (Primary Adrenal Insufficiency)

• What it is. Autoimmune destruction of adrenal glands causing cortisol and aldosterone deficiency.

• Clinical presentation. Fatigue, weight loss, hypotension, salt cravings, hyperpigmentation (skin creases, scars, gums), nausea; adrenal crisis can be fatal.

• How to diagnose. Morning cortisol (low), ACTH (high), ACTH stimulation test, 21-hydroxylase antibodies.

• Common misdiagnoses. Depression, chronic fatigue syndrome, eating disorders, GI disease, sepsis.

• How to prevent diagnostic errors. Hyperpigmentation is the most specific clue; check morning cortisol if symptoms fit; hyponatremia + hyperkalemia is near-pathognomonic.

• Medical treatment. Hydrocortisone (15-25 mg/day) + fludrocortisone; stress dosing; emergency injection kit; medical alert bracelet.

• Natural/lifestyle treatment. Adequate salt intake; stress management; avoid overexertion during illness.

• Drugs that worsen. Rifampin, phenytoin, phenobarbital (increase cortisol metabolism).

• Food effects. Adequate salt intake; licorice can worsen (mimics aldosterone).

• Harms to self. Adrenal crisis (fatal if untreated), osteoporosis, cardiovascular disease.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Not curable; lifelong hormone replacement required.

17. Autoimmune Hemolytic Anemia

• What it is. Antibodies destroy red blood cells causing hemolysis.

• Clinical presentation. Fatigue, pallor, jaundice, dark urine, dyspnea, tachycardia, splenomegaly.

• How to diagnose. CBC (anemia), reticulocyte count (elevated), direct Coombs test (positive), elevated LDH, low haptoglobin.

• Common misdiagnoses. Iron deficiency anemia, B12/folate deficiency, TTP, PNH, hereditary spherocytosis.

• How to prevent diagnostic errors. Positive direct Coombs test is key; distinguish warm (IgG) from cold (IgM/C3d) AIHA.

• Medical treatment. Corticosteroids; rituximab; splenectomy; immunosuppressants.

• Natural/lifestyle treatment. Folic acid supplementation; avoid cold exposure if cold AIHA.

• Drugs that worsen. Cephalosporins, penicillin, methyldopa (drug-induced AIHA).

• Food effects. Folic acid-rich foods help (increased demand from hemolysis).

• Harms to self. Severe anemia, thrombosis, renal failure.

• Harms to others. None directly.

• Can it be overcome? Many achieve remission; some require long-term treatment.

18. Primary Biliary Cholangitis

• What it is. Autoimmune destruction of small bile ducts in the liver.

• Clinical presentation. Fatigue, pruritus, dry eyes/mouth, elevated alkaline phosphatase, jaundice in advanced disease.

• How to diagnose. Anti-mitochondrial antibodies (95% positive), elevated ALP, liver biopsy.

• Common misdiagnoses. NAFLD, drug-induced cholestasis, PSC, sarcoidosis, IgG4-related sclerosing cholangitis.

• How to prevent diagnostic errors. AMA-positive + elevated ALP is highly suggestive; rarely considered in men.

• Medical treatment. Ursodeoxycholic acid (UDCA); obeticholic acid; fibrates (bezafibrate).

• Natural/lifestyle treatment. Calcium and vitamin D; exercise; cholestyramine for itch.

• Drugs that worsen. Chlorpromazine (cholestatic).

• Food effects. Adequate calcium and vitamin D important.

• Harms to self. Cirrhosis, portal hypertension, osteoporosis, fat-soluble vitamin deficiency.

• Harms to others. None directly.

• Can it be overcome? UDCA slows progression; liver transplant for end-stage disease.

19. Sjogren's Syndrome

• What it is. Immune attack on moisture-producing glands.

• Clinical presentation. Dry eyes, dry mouth, dental cavities, dysphagia, joint pain, fatigue; can affect lungs, kidneys, nerves; rarely considered in men.

• How to diagnose. Anti-SSA (Ro), anti-SSB (La), Schirmer's test, salivary gland biopsy, ocular staining.

• Common misdiagnoses. Medication side effects, aging, dehydration, diabetes, sarcoidosis, IgG4-RD.

• How to prevent diagnostic errors. Dry eyes/mouth in men is often attributed to medications or aging; biopsy if uncertain.

• Medical treatment. Artificial tears; saliva substitutes; pilocarpine; cevimeline; hydroxychloroquine; rituximab.

• Natural/lifestyle treatment. Hydration; humidifiers; sugar-free gum; regular dental care.

• Drugs that worsen. Anticholinergics, antihistamines, diuretics (worsen dryness).

• Food effects. Hydration; avoid caffeine and alcohol (worsen dryness).

• Harms to self. Lymphoma (40-fold increased risk), dental decay, corneal damage, neuropathy.

• Harms to others. None directly.

• Can it be overcome? Chronic; symptom management; lymphoma surveillance essential.

20. Systemic Sclerosis (Scleroderma)

• What it is. Immune-driven fibrosis of skin and internal organs.

• Clinical presentation. Raynaud's, skin thickening, dysphagia, GERD, pulmonary fibrosis, renal crisis (severe hypertension and AKI).

• How to diagnose. ANA, anti-centromere (limited), anti-Scl-70 (diffuse), anti-RNA polymerase III, nailfold capillaroscopy, PFTs, echo.

• Common misdiagnoses. Raynaud's disease (primary), eosinophilic fasciitis, morphea, CREST syndrome.

• How to prevent diagnostic errors. Raynaud's + skin thickening + nailfold capillary changes = scleroderma; anti-RNA polymerase III flags higher cancer risk.

• Medical treatment. ACE inhibitors (renal crisis); PPIs; mycophenolate; cyclophosphamide; tocilizumab; nintedanib (pulmonary fibrosis).

• Natural/lifestyle treatment. Cold avoidance; smoking cessation; head-of-bed elevation; exercise.

• Drugs that worsen. Bleomycin (causes pulmonary fibrosis); cocaine (worsens Raynaud's).

• Food effects. Small frequent meals for GERD; avoid cold foods/drinks.

• Harms to self. Pulmonary fibrosis, pulmonary hypertension, renal crisis, digital ulcers.

• Harms to others. Genetic susceptibility.

• Can it be overcome? No cure; organ-specific treatment; autologous stem cell transplant for severe cases.

21. Vitiligo

• What it is. Immune destruction of melanocytes causing depigmentation.

• Clinical presentation. Well-defined white patches on face, hands, body folds; more noticeable in darker skin; often first noticed in summer.

• How to diagnose. Clinical appearance; Wood's lamp; screen for associated autoimmune diseases.

• Common misdiagnoses. Tinea versicolor, pityriasis alba, post-inflammatory hypopigmentation, chemical leukoderma.

• How to prevent diagnostic errors. Wood's lamp enhances contrast; check thyroid function and B12.

• Medical treatment. Topical corticosteroids; calcineurin inhibitors; NB-UVB phototherapy; ruxolitinib cream (FDA-approved).

• Natural/lifestyle treatment. Sun protection of depigmented areas; cosmetic camouflage.

• Drugs that worsen. None specific.

• Food effects. Antioxidant-rich diet may help.

• Harms to self. Sunburn risk, psychological distress, associated autoimmune diseases.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Repigmentation possible with months of treatment.

22. Polymyalgia Rheumatica

• What it is. Inflammatory condition causing shoulder/hip pain and stiffness in patients over 50.

• Clinical presentation. Bilateral shoulder/hip pain, morning stiffness over 45 minutes, difficulty raising arms, difficulty rising from chair, fatigue.

• How to diagnose. Markedly elevated ESR/CRP; clinical presentation; always screen for giant cell arteritis.

• Common misdiagnoses. RA, rotator cuff disease, fibromyalgia, hypothyroidism, malignancy, infection.

• How to prevent diagnostic errors. Dramatic response to low-dose prednisone within days; if no response, reconsider.

• Medical treatment. Low-dose prednisone (12.5-25 mg/day) with gradual taper over 1-2 years.

• Natural/lifestyle treatment. Exercise; calcium and vitamin D for steroid-induced osteoporosis.

• Drugs that worsen. None specific.

• Food effects. Calcium and vitamin D important during steroid use.

• Harms to self. GCA (15-20%), steroid side effects, osteoporosis, diabetes.

• Harms to others. None directly.

• Can it be overcome? Usually self-limited over 1-3 years; most taper off steroids.

23. Autoimmune Pancreatitis

• What it is. Immune-mediated pancreatic inflammation; Type 1 (IgG4-related) more common in older men.

• Clinical presentation. Painless jaundice, mild abdominal discomfort, weight loss, new-onset diabetes; mimics pancreatic cancer.

• How to diagnose. Elevated serum IgG4; CT (sausage-shaped pancreas); biopsy showing IgG4-positive plasma cells.

• Common misdiagnoses. Pancreatic cancer, cholangiocarcinoma, chronic pancreatitis, lymphoma.

• How to prevent diagnostic errors. If a pancreatic mass responds to steroids, it's likely AIP; check IgG4 before surgery.

• Medical treatment. Corticosteroids (dramatic response); rituximab; azathioprine/mycophenolate for maintenance.

• Natural/lifestyle treatment. No specific natural treatments.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Pancreatic insufficiency, diabetes, biliary strictures.

• Harms to others. None directly.

• Can it be overcome? Dramatic steroid response; relapse common (30-60%).

24. Guillain-Barre Syndrome

• What it is. Acute immune attack on peripheral nerves; often post-infectious; slightly more common in men.

• Clinical presentation. Ascending weakness, tingling, areflexia, facial weakness, respiratory failure; progresses over days to weeks.

• How to diagnose. Clinical presentation; nerve conduction studies; lumbar puncture (elevated protein, normal cell count).

• Common misdiagnoses. Transverse myelitis, myasthenia gravis, botulism, spinal cord compression, tick paralysis.

• How to prevent diagnostic errors. Rapid ascending weakness + areflexia = GBS; monitor respiratory function closely.

• Medical treatment. IVIG or plasmapheresis (equally effective); ICU monitoring for respiratory failure; NOT corticosteroids.

• Natural/lifestyle treatment. Physical rehabilitation; occupational therapy.

• Drugs that worsen. Corticosteroids NOT effective; avoid neurotoxic drugs during recovery.

• Food effects. No specific food effects.

• Harms to self. Respiratory failure, autonomic instability, chronic pain, residual weakness.

• Harms to others. None directly.

• Can it be overcome? Most recover; 80% walk independently at 6 months; some have residual deficits.

25. Pemphigus Vulgaris

• What it is. Antibodies attack desmoglein proteins causing intraepidermal blistering.

• Clinical presentation. Painful oral erosions (often first sign), fragile skin blisters, positive Nikolsky sign.

• How to diagnose. Skin biopsy with DIF (intercellular IgG), anti-Dsg1/Dsg3 antibodies.

• Common misdiagnoses. Aphthous ulcers, herpes simplex, erythema multiforme, bullous pemphigoid, lichen planus.

• How to prevent diagnostic errors. Persistent oral erosions not responding to standard treatment require biopsy with DIF.

• Medical treatment. Rituximab (increasingly first-line); corticosteroids; mycophenolate; azathioprine.

• Natural/lifestyle treatment. Soft diet; gentle oral care; wound care.

• Drugs that worsen. None specific.

• Food effects. Soft, non-spicy, non-acidic foods for oral lesions.

• Harms to self. Secondary infection, fluid/electrolyte loss, death if untreated.

• Harms to others. None directly.

• Can it be overcome? Rituximab can induce prolonged remission; historically fatal without treatment.

26. IgA Nephropathy (Berger's Disease)

• What it is. IgA deposits in kidneys causing glomerulonephritis; most common GN worldwide; more common in men.

• Clinical presentation. Hematuria (often during/after URI = synpharyngitic), proteinuria, hypertension.

• How to diagnose. Urinalysis, kidney biopsy (IgA deposits on immunofluorescence).

• Common misdiagnoses. UTI, kidney stones, bladder cancer, thin basement membrane disease, post-streptococcal GN.

• How to prevent diagnostic errors. Visible hematuria during or after URI is classic; biopsy required for definitive diagnosis.

• Medical treatment. ACE inhibitors/ARBs; SGLT2 inhibitors; corticosteroids; sparsentan; fish oil.

• Natural/lifestyle treatment. Omega-3 fatty acids; low-sodium diet; adequate hydration.

• Drugs that worsen. NSAIDs worsen kidney function.

• Food effects. Low-sodium diet; omega-3 may help.

• Harms to self. End-stage kidney disease (40-50% over 20 years), hypertension.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Variable; some stable for decades; SGLT2 inhibitors and sparsentan improve outcomes.

27. Antiphospholipid Syndrome

• What it is. Autoantibodies cause abnormal blood clotting.

• Clinical presentation. DVT, PE, stroke, livedo reticularis, recurrent pregnancy loss (in female partners).

• How to diagnose. Anticardiolipin, anti-beta-2 GP1, lupus anticoagulant (positive twice, 12 weeks apart).

• Common misdiagnoses. DVT from other causes, inherited thrombophilia, DIC, HIT, vasculitis.

• How to prevent diagnostic errors. Unexplained thrombosis in unusual sites or at young age should prompt APS testing.

• Medical treatment. Warfarin (preferred over DOACs); aspirin; hydroxychloroquine.

• Natural/lifestyle treatment. Smoking cessation; avoid prolonged immobility; adequate hydration.

• Drugs that worsen. DOACs inferior to warfarin in APS; estrogen-containing contraceptives.

• Food effects. Consistent vitamin K intake with warfarin.

• Harms to self. Catastrophic APS (multi-organ failure), stroke, PE, renal failure.

• Harms to others. Neonatal lupus if anti-Ro antibodies coexist.

• Can it be overcome? Lifelong anticoagulation required; catastrophic APS has high mortality.

28. Dermatomyositis and Polymyositis

• What it is. Immune attack on muscles (PM) or muscles plus skin (DM); cancer risk in men over 40 with DM.

• Clinical presentation. Proximal weakness, heliotrope rash (DM), Gottron's papules (DM), V-sign rash, dysphagia.

• How to diagnose. Elevated CK, myositis-specific antibodies, EMG, muscle MRI, muscle biopsy; cancer screening.

• Common misdiagnoses. Hypothyroidism, statin myopathy, muscular dystrophy, inclusion body myositis, fibromyalgia.

• How to prevent diagnostic errors. In men over 40 with DM, cancer screening is mandatory; anti-TIF1-gamma flags malignancy.

• Medical treatment. Corticosteroids; methotrexate; azathioprine; mycophenolate; IVIG; rituximab.

• Natural/lifestyle treatment. Exercise/physical therapy; sun protection (DM); cancer surveillance.

• Drugs that worsen. Statins (can trigger necrotizing myopathy); checkpoint inhibitors.

• Food effects. Sun avoidance for DM; anti-inflammatory diet.

• Harms to self. Cancer (DM), interstitial lung disease, dysphagia, cardiac involvement.

• Harms to others. None directly.

• Can it be overcome? Variable; many respond to treatment; cancer-associated DM depends on tumor outcome.

29. Alopecia Areata

• What it is. Immune attack on hair follicles causing patchy hair loss.

• Clinical presentation. Smooth round patches of hair loss, exclamation point hairs; can progress to totalis/universalis.

• How to diagnose. Clinical appearance, dermoscopy, biopsy if uncertain.

• Common misdiagnoses. Tinea capitis, trichotillomania, telogen effluvium, secondary syphilis, androgenetic alopecia.

• How to prevent diagnostic errors. Smooth patches without scaling favor alopecia areata; fungal infections have scaling.

• Medical treatment. Topical/intralesional corticosteroids; JAK inhibitors (baricitinib, ritlecitinib); minoxidil; DPCP.

• Natural/lifestyle treatment. Stress management; many mild cases regrow spontaneously within a year.

• Drugs that worsen. None specific.

• Food effects. Adequate protein and iron support hair health.

• Harms to self. Psychological distress, progression to totalis/universalis.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Many regrow spontaneously; JAK inhibitors highly effective for severe cases.

30. Primary Sclerosing Cholangitis

• What it is. Chronic bile duct inflammation/scarring; more common in men (2:1); strongly associated with UC.

• Clinical presentation. Fatigue, pruritus, jaundice, RUQ pain, recurrent cholangitis.

• How to diagnose. Elevated ALP, MRCP (bile duct beading), liver biopsy (onion-skin fibrosis), p-ANCA.

• Common misdiagnoses. Gallstones, PBC, IgG4-SC, cholangiocarcinoma, drug-induced cholestasis.

• How to prevent diagnostic errors. Any man with UC + elevated liver enzymes should be evaluated for PSC.

• Medical treatment. No proven medical therapy; endoscopic management of strictures; liver transplant for end-stage disease.

• Natural/lifestyle treatment. Avoid alcohol; regular exercise; cancer surveillance.

• Drugs that worsen. UDCA is controversial in PSC (unlike PBC).

• Food effects. No specific food effects.

• Harms to self. Cholangiocarcinoma, colon cancer, gallbladder cancer, cirrhosis.

• Harms to others. Genetic susceptibility.

• Can it be overcome? No medical cure; liver transplant for end-stage disease; recurrence possible post-transplant.

31. Autoimmune Orchitis

• What it is. Immune attack on the testes causing inflammation and potential infertility.

• Clinical presentation. Testicular pain, swelling, tenderness, infertility, low testosterone.

• How to diagnose. Semen analysis, anti-sperm antibodies, testicular ultrasound, hormone panel, biopsy if needed.

• Common misdiagnoses. Epididymitis, testicular torsion, testicular cancer, mumps orchitis, varicocele.

• How to prevent diagnostic errors. Unilateral testicular pain with negative infection workup should prompt autoimmune evaluation.

• Medical treatment. Corticosteroids; immunosuppressants; assisted reproduction (IVF/ICSI).

• Natural/lifestyle treatment. Scrotal support; ice packs; stress management.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Infertility, hypogonadism, testicular atrophy.

• Harms to others. Infertility (inability to conceive).

• Can it be overcome? Variable; fertility may be restored with treatment or assisted reproduction.

32. Autoimmune Encephalitis

• What it is. Antibodies attack brain receptors causing neuropsychiatric symptoms; includes NMDAR, LGI1, CASPR2 subtypes.

• Clinical presentation. Personality changes, memory loss, seizures, psychosis, movement disorders, autonomic instability.

• How to diagnose. Anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR antibodies; MRI; EEG; CSF.

• Common misdiagnoses. Schizophrenia, bipolar disorder, viral encephalitis, drug intoxication, dementia, epilepsy.

• How to prevent diagnostic errors. New-onset psychiatric symptoms + seizures or movement disorder = autoimmune encephalitis until proven otherwise.

• Medical treatment. IVIG; corticosteroids; plasma exchange; rituximab; cyclophosphamide; tumor removal if paraneoplastic.

• Natural/lifestyle treatment. Supportive care; rehabilitation; cognitive therapy.

• Drugs that worsen. Antipsychotics may mask symptoms and delay diagnosis.

• Food effects. No specific food effects.

• Harms to self. Status epilepticus, coma, cognitive deficits, death if untreated.

• Harms to others. Behavioral changes may affect relationships.

• Can it be overcome? Many recover with early treatment; NMDAR encephalitis has good prognosis if treated early.

33. Immune Thrombocytopenic Purpura

• What it is. Antibodies destroy platelets causing low platelet count and bleeding risk.

• Clinical presentation. Easy bruising, petechiae, mucosal bleeding, heavy nosebleeds, GI bleeding, intracranial hemorrhage (rare).

• How to diagnose. CBC (isolated thrombocytopenia), peripheral smear, exclude HIV/HCV/lupus/MDS.

• Common misdiagnoses. Leukemia, MDS, TTP, DIC, drug-induced thrombocytopenia, liver disease.

• How to prevent diagnostic errors. Isolated thrombocytopenia with normal WBC/RBC = ITP; check peripheral smear to exclude TTP.

• Medical treatment. Corticosteroids; IVIG; rituximab; TPO receptor agonists (eltrombopag, romiplostim); splenectomy; fostamatinib.

• Natural/lifestyle treatment. Avoid contact sports; avoid aspirin/NSAIDs; stress management.

• Drugs that worsen. NSAIDs, aspirin, anticoagulants increase bleeding; quinine, heparin cause drug-induced TCP.

• Food effects. No specific food effects; avoid alcohol.

• Harms to self. Life-threatening bleeding, intracranial hemorrhage.

• Harms to others. None directly.

• Can it be overcome? Many achieve remission; chronic ITP manageable with TPO agonists.

34. Sarcoidosis

• What it is. Granulomatous inflammation of multiple organs; more common and severe in Black men.

• Clinical presentation. Bilateral hilar lymphadenopathy, cough, skin lesions (erythema nodosum, lupus pernio), uveitis, fatigue, cardiac involvement.

• How to diagnose. Chest imaging, biopsy (non-caseating granulomas), ACE level, calcium, PFTs, ECG/cardiac MRI.

• Common misdiagnoses. Lymphoma, tuberculosis, fungal infection, lung cancer, berylliosis.

• How to prevent diagnostic errors. Non-caseating granulomas + compatible clinical picture; must exclude infection and malignancy.

• Medical treatment. Corticosteroids; methotrexate; azathioprine; mycophenolate; infliximab.

• Natural/lifestyle treatment. Vitamin D monitoring (avoid excess); exercise; sun protection; stress management.

• Drugs that worsen. Checkpoint inhibitors can trigger.

• Food effects. Avoid excessive vitamin D and calcium supplementation (hypercalcemia risk).

• Harms to self. Pulmonary fibrosis, cardiac arrhythmia/sudden death, blindness, kidney failure.

• Harms to others. None directly.

• Can it be overcome? Many resolve spontaneously; chronic sarcoidosis requires long-term treatment.

35. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

• What it is. Chronic immune attack on peripheral nerve myelin; more common in men.

• Clinical presentation. Progressive symmetric proximal and distal weakness, numbness, tingling, areflexia; evolves over more than 8 weeks.

• How to diagnose. NCS (demyelination), CSF (elevated protein), nerve ultrasound/MRI, nerve biopsy if needed.

• Common misdiagnoses. Diabetic neuropathy, GBS (if acute), hereditary neuropathy (CMT), POEMS, multifocal motor neuropathy.

• How to prevent diagnostic errors. Progression over 8 weeks distinguishes from GBS; check for POEMS if treatment-refractory.

• Medical treatment. IVIG; corticosteroids; plasma exchange; rituximab; mycophenolate.

• Natural/lifestyle treatment. Exercise; physical therapy; occupational therapy.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Progressive disability, falls, respiratory compromise (rare).

• Harms to others. None directly.

• Can it be overcome? Most respond to treatment; many require long-term maintenance therapy.

36. Autoimmune Myocarditis

• What it is. Immune attack on heart muscle; can be triggered by checkpoint inhibitors or viral infection.

• Clinical presentation. Chest pain, dyspnea, palpitations, heart failure, arrhythmias, cardiogenic shock.

• How to diagnose. Troponin, BNP, ECG, echocardiogram, cardiac MRI (late gadolinium enhancement), endomyocardial biopsy.

• Common misdiagnoses. Acute MI, viral myocarditis, stress cardiomyopathy, PE, pericarditis.

• How to prevent diagnostic errors. Any patient on checkpoint inhibitors with new cardiac symptoms needs urgent troponin and ECG.

• Medical treatment. High-dose corticosteroids (ICI-related); IVIG; mycophenolate; heart failure management.

• Natural/lifestyle treatment. Rest during acute phase; cardiac rehabilitation after recovery.

• Drugs that worsen. Checkpoint inhibitors (major trigger); sympathomimetics.

• Food effects. Low-sodium diet for heart failure.

• Harms to self. Heart failure, fatal arrhythmia, cardiogenic shock, death.

• Harms to others. None directly.

• Can it be overcome? ICI-related myocarditis: high mortality if not caught early; viral-triggered may recover.

37. Stiff Person Syndrome

• What it is. Antibodies (anti-GAD65) cause progressive muscle stiffness and spasms.

• Clinical presentation. Progressive axial stiffness, painful spasms triggered by noise/touch/emotion, exaggerated startle, falls.

• How to diagnose. Anti-GAD65 antibodies (very high titers), anti-amphiphysin, EMG (continuous motor unit activity).

• Common misdiagnoses. Fibromyalgia, MS, Parkinson's, anxiety disorder, conversion disorder, tetanus.

• How to prevent diagnostic errors. Very high anti-GAD65 titers are characteristic; EMG shows continuous motor unit activity.

• Medical treatment. Diazepam/baclofen (symptom relief); IVIG; rituximab; corticosteroids; plasma exchange.

• Natural/lifestyle treatment. Stress management; gentle stretching; fall prevention; psychological support.

• Drugs that worsen. Stimulants, caffeine (worsen spasms).

• Food effects. No specific food effects.

• Harms to self. Falls, fractures, respiratory compromise, severe disability.

• Harms to others. None directly.

• Can it be overcome? Chronic and progressive; symptoms manageable but disease not curable.

38. Neuromyelitis Optica Spectrum Disorder (NMOSD)

• What it is. Anti-AQP4 antibodies attack optic nerves and spinal cord.

• Clinical presentation. Severe optic neuritis (often bilateral), longitudinally extensive transverse myelitis, intractable hiccups/vomiting.

• How to diagnose. Anti-AQP4 antibodies, MRI (longitudinally extensive myelitis over 3 segments), exclude MS.

• Common misdiagnoses. Multiple sclerosis (critical distinction), stroke, spinal cord tumor, sarcoidosis.

• How to prevent diagnostic errors. MS drugs (interferons, natalizumab, fingolimod) WORSEN NMOSD; always test AQP4 before MS therapy.

• Medical treatment. Eculizumab; inebilizumab; satralizumab; rituximab; acute: IV methylprednisolone, plasma exchange.

• Natural/lifestyle treatment. Stress management; rehabilitation; vision aids.

• Drugs that worsen. MS disease-modifying therapies (worsen NMOSD).

• Food effects. No specific food effects.

• Harms to self. Blindness, paralysis, respiratory failure, death.

• Harms to others. None directly.

• Can it be overcome? Relapse prevention with biologics is effective; accumulated disability from attacks.

39. Autoimmune Polyendocrine Syndromes (APS-1 and APS-2)

• What it is. Clusters of autoimmune endocrine diseases; APS-1 (AIRE gene), APS-2 (polygenic).

• Clinical presentation. APS-1: mucocutaneous candidiasis, hypoparathyroidism, Addison's. APS-2: Addison's + thyroid disease + T1D.

• How to diagnose. Organ-specific antibodies, AIRE gene testing (APS-1), hormone panels.

• Common misdiagnoses. Individual endocrine diseases diagnosed in isolation without recognizing the syndrome.

• How to prevent diagnostic errors. When one autoimmune endocrine disease is found, screen for others; family history is key.

• Medical treatment. Hormone replacement for each deficiency; immunosuppression for APS-1 complications.

• Natural/lifestyle treatment. Stress management; medical alert bracelet; regular screening.

• Drugs that worsen. Checkpoint inhibitors can trigger multiple endocrinopathies.

• Food effects. No specific food effects.

• Harms to self. Adrenal crisis, hypoglycemia, multi-organ failure.

• Harms to others. Genetic susceptibility (especially APS-1).

• Can it be overcome? Not curable; lifelong hormone replacement and surveillance.

40. Mixed Connective Tissue Disease

• What it is. Overlap of lupus, scleroderma, polymyositis with high-titer anti-U1 RNP antibodies.

• Clinical presentation. Raynaud's, swollen sausage fingers, arthritis, myositis, esophageal dysmotility, pulmonary hypertension.

• How to diagnose. High-titer anti-U1 RNP antibodies, ANA, CK, PFTs, echocardiogram.

• Common misdiagnoses. Lupus, scleroderma, polymyositis, RA, undifferentiated CTD.

• How to prevent diagnostic errors. High-titer anti-U1 RNP + overlap features = MCTD; may evolve into a defined CTD.

• Medical treatment. Corticosteroids; hydroxychloroquine; methotrexate; mycophenolate; calcium channel blockers (Raynaud's).

• Natural/lifestyle treatment. Cold avoidance; exercise; anti-inflammatory diet.

• Drugs that worsen. Bleomycin, cocaine (worsen Raynaud's).

• Food effects. No specific food effects.

• Harms to self. Pulmonary hypertension (leading cause of death), renal disease, esophageal stricture.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Variable; some evolve into lupus or scleroderma; pulmonary hypertension is the major threat.

41. IgG4-Related Disease

• What it is. Fibroinflammatory condition with IgG4+ plasma cell infiltration; more common in older men.

• Clinical presentation. Painless organ swelling (salivary glands, pancreas, kidneys, aorta, orbits), weight loss, new diabetes.

• How to diagnose. Elevated serum IgG4 (not always), biopsy (storiform fibrosis, IgG4+ plasma cells), PET/CT.

• Common misdiagnoses. Lymphoma, sarcoidosis, Sjogren's, pancreatic cancer, GPA, Castleman disease.

• How to prevent diagnostic errors. Biopsy is essential; elevated IgG4 alone is not diagnostic (low specificity).

• Medical treatment. Corticosteroids (dramatic response); rituximab; mycophenolate; azathioprine.

• Natural/lifestyle treatment. No specific natural treatments.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Organ fibrosis, aortic aneurysm, kidney failure, biliary obstruction.

• Harms to others. None directly.

• Can it be overcome? Steroid-responsive but relapse common; rituximab effective for refractory disease.

42. Membranous Nephropathy

• What it is. Antibodies (anti-PLA2R) attack kidney glomeruli; most common cause of nephrotic syndrome in white men.

• Clinical presentation. Edema (legs, face), foamy urine, fatigue, weight gain, hyperlipidemia, hypercoagulability.

• How to diagnose. Anti-PLA2R antibodies, kidney biopsy (subepithelial deposits), 24-hour urine protein.

• Common misdiagnoses. Diabetic nephropathy, minimal change disease, FSGS, lupus nephritis, amyloidosis.

• How to prevent diagnostic errors. Anti-PLA2R antibodies are 70% sensitive and highly specific; cancer screening in PLA2R-negative patients over 50.

• Medical treatment. ACE inhibitors/ARBs; rituximab; cyclophosphamide + corticosteroids; calcineurin inhibitors.

• Natural/lifestyle treatment. Low-sodium diet; exercise; smoking cessation.

• Drugs that worsen. NSAIDs worsen kidney function.

• Food effects. Low-sodium diet; adequate (not excessive) protein.

• Harms to self. End-stage kidney disease, thromboembolism, infection.

• Harms to others. None directly.

• Can it be overcome? One-third spontaneously remit; rituximab highly effective.

43. Bullous Pemphigoid

• What it is. Antibodies attack basement membrane causing subepidermal blisters; most common autoimmune blistering disease.

• Clinical presentation. Tense blisters on trunk and extremities, intense itching, urticarial plaques; elderly patients.

• How to diagnose. Skin biopsy with DIF (linear IgG/C3 at BMZ), anti-BP180/BP230 antibodies.

• Common misdiagnoses. Drug eruption, contact dermatitis, scabies, dermatitis herpetiformis, pemphigus vulgaris.

• How to prevent diagnostic errors. Tense blisters (not flaccid) + elderly patient + intense itch = BP; DIF is gold standard.

• Medical treatment. Topical clobetasol (mild-moderate); doxycycline; rituximab; omalizumab; systemic steroids.

• Natural/lifestyle treatment. Gentle skin care; wound care; adequate nutrition.

• Drugs that worsen. DPP-4 inhibitors (gliptins), PD-1/PD-L1 inhibitors, loop diuretics, spironolactone.

• Food effects. No specific food effects.

• Harms to self. Secondary infection, sepsis, mortality (especially in elderly).

• Harms to others. None directly.

• Can it be overcome? Most respond to treatment; mortality higher in elderly due to comorbidities.

44. Epidermolysis Bullosa Acquisita

• What it is. Antibodies against type VII collagen causing skin fragility and blistering.

• Clinical presentation. Skin fragility, blisters at trauma sites (hands, feet, elbows, knees), scarring, milia, nail dystrophy.

• How to diagnose. Skin biopsy with DIF (linear IgG at BMZ), anti-type VII collagen antibodies, salt-split skin (dermal binding).

• Common misdiagnoses. Bullous pemphigoid, porphyria cutanea tarda, hereditary EB, linear IgA disease.

• How to prevent diagnostic errors. Dermal-side binding on salt-split skin distinguishes EBA from BP (epidermal-side).

• Medical treatment. Colchicine; dapsone; rituximab; IVIG; mycophenolate; avoid skin trauma.

• Natural/lifestyle treatment. Gentle skin care; padded clothing; wound care; avoid trauma.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Scarring, contractures, esophageal strictures, vision loss.

• Harms to others. None directly.

• Can it be overcome? Chronic and difficult to treat; rituximab shows promise.

45. Linear IgA Bullous Dermatosis

• What it is. IgA antibodies at basement membrane causing blistering; can be drug-induced.

• Clinical presentation. Tense blisters in cluster of jewels pattern; oral involvement possible.

• How to diagnose. Skin biopsy with DIF (linear IgA at BMZ).

• Common misdiagnoses. Bullous pemphigoid, dermatitis herpetiformis, pemphigus, drug eruption.

• How to prevent diagnostic errors. Linear IgA (not granular) on DIF distinguishes from dermatitis herpetiformis; check medication history.

• Medical treatment. Dapsone (first-line); colchicine; mycophenolate; stop offending drug.

• Natural/lifestyle treatment. Wound care; gentle skin care.

• Drugs that worsen. Vancomycin (most common drug trigger), lithium, NSAIDs, captopril.

• Food effects. No specific food effects.

• Harms to self. Secondary infection, scarring.

• Harms to others. None directly.

• Can it be overcome? Drug-induced form resolves after stopping drug; idiopathic form is chronic.

46. Eosinophilic Granulomatosis with Polyangiitis (EGPA/Churg-Strauss)

• What it is. Small-vessel vasculitis with asthma, eosinophilia, and granulomas.

• Clinical presentation. Late-onset asthma, sinusitis, peripheral neuropathy (mononeuritis multiplex), cardiac involvement, skin purpura.

• How to diagnose. Eosinophilia, ANCA (p-ANCA/MPO in ~40%), biopsy, cardiac MRI.

• Common misdiagnoses. Asthma with eosinophilia, hypereosinophilic syndrome, GPA, PAN, parasitic infection.

• How to prevent diagnostic errors. New peripheral neuropathy in an asthmatic with eosinophilia = EGPA until proven otherwise.

• Medical treatment. Corticosteroids; mepolizumab (FDA-approved for EGPA); cyclophosphamide; rituximab.

• Natural/lifestyle treatment. Smoking cessation; exercise; asthma management.

• Drugs that worsen. Leukotriene receptor antagonists may unmask EGPA when steroids are tapered.

• Food effects. No specific food effects.

• Harms to self. Cardiac death (leading cause of mortality), neuropathy, kidney failure.

• Harms to others. None directly.

• Can it be overcome? Mepolizumab has improved outcomes; cardiac involvement determines prognosis.

47. Takayasu Arteritis

• What it is. Large-vessel vasculitis affecting the aorta and its branches; affects young adults.

• Clinical presentation. Limb claudication, absent/diminished pulses, BP discrepancy between arms, bruits, stroke, aortic regurgitation.

• How to diagnose. CTA/MRA (vessel wall thickening, stenosis), PET/CT, ESR/CRP.

• Common misdiagnoses. Atherosclerosis, fibromuscular dysplasia, GCA, aortic dissection, coarctation of aorta.

• How to prevent diagnostic errors. BP discrepancy + absent pulses in young person = Takayasu; check BP in both arms.

• Medical treatment. Corticosteroids; methotrexate; azathioprine; tocilizumab; TNF inhibitors; vascular surgery/stenting.

• Natural/lifestyle treatment. Exercise within limits; anti-inflammatory diet; smoking cessation.

• Drugs that worsen. None specific.

• Food effects. Anti-inflammatory diet may help.

• Harms to self. Stroke, aortic aneurysm, heart failure, limb ischemia.

• Harms to others. None directly.

• Can it be overcome? Chronic; remission achievable but relapses common; vascular damage may be permanent.

48. Relapsing Polychondritis

• What it is. Immune attack on cartilage throughout the body.

• Clinical presentation. Red swollen painful ears (sparing earlobes), saddle nose deformity, airway collapse, joint pain, eye inflammation.

• How to diagnose. Clinical (Damiani/Levine or McAdam criteria), biopsy of affected cartilage, CT airway.

• Common misdiagnoses. Cellulitis of ear, GPA, VEXAS, IgG4-RD, infectious perichondritis.

• How to prevent diagnostic errors. Ear inflammation sparing the earlobe is classic (earlobe has no cartilage); check for airway involvement; rule out VEXAS in older men.

• Medical treatment. Corticosteroids; dapsone; methotrexate; azathioprine; biologics (infliximab, tocilizumab); airway stenting.

• Natural/lifestyle treatment. Stress management; avoid ear trauma.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Airway collapse (life-threatening), hearing loss, saddle nose, aortic aneurysm.

• Harms to others. None directly.

• Can it be overcome? Chronic; airway involvement determines prognosis; biologics help refractory cases.

49. Vogt-Koyanagi-Harada Disease

• What it is. Autoimmune attack on melanocytes in eyes, skin, meninges, and inner ear.

• Clinical presentation. Bilateral panuveitis, headache, meningismus, hearing loss, vitiligo, poliosis (white eyelashes/hair).

• How to diagnose. Fundoscopy (exudative retinal detachments), OCT, fluorescein angiography, LP (lymphocytic pleocytosis).

• Common misdiagnoses. Posterior uveitis from other causes, sarcoidosis, sympathetic ophthalmia, lymphoma, syphilis.

• How to prevent diagnostic errors. Bilateral uveitis + headache + hearing loss + skin depigmentation = VKH; more common in pigmented individuals.

• Medical treatment. High-dose IV corticosteroids then oral taper; immunosuppressants (mycophenolate, azathioprine, cyclosporine).

• Natural/lifestyle treatment. Sun protection; stress management.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Blindness, chronic uveitis, glaucoma, cataracts.

• Harms to others. Genetic susceptibility (HLA-DR4).

• Can it be overcome? Early aggressive treatment prevents chronic disease; delayed treatment leads to poor outcomes.

50. Cogan Syndrome

• What it is. Autoimmune attack on eyes and inner ear; rare.

• Clinical presentation. Interstitial keratitis (eye pain, redness, photophobia), sensorineural hearing loss, vertigo; can have systemic vasculitis.

• How to diagnose. Clinical presentation, audiometry, slit-lamp exam, CRP/ESR, aortic imaging.

• Common misdiagnoses. Syphilis (must exclude), Meniere's disease, GPA, sarcoidosis, viral labyrinthitis.

• How to prevent diagnostic errors. Non-syphilitic interstitial keratitis + audiovestibular dysfunction = Cogan; RPR/VDRL to exclude syphilis.

• Medical treatment. Corticosteroids; methotrexate; cyclophosphamide; TNF inhibitors; cochlear implant for deafness.

• Natural/lifestyle treatment. Hearing aids; vestibular rehabilitation.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Deafness, blindness, aortic insufficiency, stroke.

• Harms to others. None directly.

• Can it be overcome? Hearing loss often permanent; cochlear implants effective; eye disease usually responds.

51. Susac Syndrome

• What it is. Autoimmune endotheliopathy affecting brain, retina, and inner ear.

• Clinical presentation. Encephalopathy (confusion, personality changes), branch retinal artery occlusions (visual field loss), sensorineural hearing loss.

• How to diagnose. MRI (snowball lesions in corpus callosum), fluorescein angiography (BRAO), audiometry.

• Common misdiagnoses. MS, CNS vasculitis, neurosyphilis, ADEM, lupus cerebritis.

• How to prevent diagnostic errors. Corpus callosum snowball lesions on MRI are characteristic and distinct from MS plaques.

• Medical treatment. IVIG; corticosteroids; plasma exchange; mycophenolate; aspirin/anticoagulation.

• Natural/lifestyle treatment. Hearing aids; visual aids; cognitive rehabilitation.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Cognitive impairment, deafness, vision loss.

• Harms to others. None directly.

• Can it be overcome? Usually self-limited (2-4 years) but can leave permanent deficits; early treatment improves outcomes.

52. Autoimmune Inner Ear Disease

• What it is. Immune attack on inner ear causing progressive hearing loss.

• Clinical presentation. Rapidly progressive bilateral sensorineural hearing loss over weeks-months, tinnitus, vertigo.

• How to diagnose. Audiometry (bilateral SNHL progressing over weeks), response to corticosteroids, exclude other causes.

• Common misdiagnoses. Meniere's disease, presbycusis, acoustic neuroma, otosclerosis, noise-induced hearing loss.

• How to prevent diagnostic errors. Bilateral hearing loss progressing over weeks (not years) that responds to steroids = AIED.

• Medical treatment. Corticosteroids; methotrexate; cyclophosphamide; biologics; cochlear implant.

• Natural/lifestyle treatment. Hearing protection; hearing aids; stress management.

• Drugs that worsen. Aminoglycosides, loop diuretics (ototoxic).

• Food effects. No specific food effects.

• Harms to self. Deafness, balance problems, social isolation.

• Harms to others. None directly.

• Can it be overcome? Early treatment can preserve hearing; delayed treatment leads to permanent loss.

53. Autoimmune Retinopathy

• What it is. Antibodies attack retinal proteins causing progressive vision loss.

• Clinical presentation. Progressive painless vision loss, photopsias (flashing lights), visual field constriction, nyctalopia.

• How to diagnose. Anti-retinal antibodies (anti-recoverin, anti-enolase), ERG (reduced), OCT, visual field; cancer screening.

• Common misdiagnoses. Retinitis pigmentosa, optic neuropathy, macular degeneration, paraneoplastic retinopathy.

• How to prevent diagnostic errors. Rapidly progressive vision loss with abnormal ERG should prompt anti-retinal antibody testing and cancer screening.

• Medical treatment. Corticosteroids; IVIG; rituximab; mycophenolate; plasma exchange; treat underlying cancer.

• Natural/lifestyle treatment. Vitamin A (controversial); low-vision aids.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Blindness.

• Harms to others. None directly.

• Can it be overcome? Variable; paraneoplastic form may stabilize with cancer treatment; non-paraneoplastic often progressive.

54. Evans Syndrome

• What it is. Simultaneous or sequential AIHA + ITP (autoimmune destruction of RBCs and platelets).

• Clinical presentation. Combined anemia symptoms (fatigue, pallor, jaundice) and thrombocytopenia (bruising, bleeding).

• How to diagnose. Positive Coombs + thrombocytopenia; exclude TTP/HUS, lupus, lymphoma, CVID.

• Common misdiagnoses. TTP, DIC, lupus, lymphoproliferative disease, bone marrow failure.

• How to prevent diagnostic errors. Evans syndrome is a diagnosis of exclusion; always evaluate for underlying cause (CVID, ALPS, lymphoma).

• Medical treatment. Corticosteroids; IVIG; rituximab; mycophenolate; splenectomy (less favored); TPO agonists.

• Natural/lifestyle treatment. Folic acid; avoid trauma; infection prevention.

• Drugs that worsen. NSAIDs, aspirin increase bleeding risk.

• Food effects. Folic acid-rich foods help.

• Harms to self. Life-threatening bleeding or anemia, infections, associated malignancy.

• Harms to others. None directly.

• Can it be overcome? Chronic relapsing; rituximab effective but relapses common.

55. Thrombotic Thrombocytopenic Purpura (TTP)

• What it is. ADAMTS13 deficiency (autoantibodies) causing microangiopathic hemolytic anemia and thrombocytopenia.

• Clinical presentation. Pentad: thrombocytopenia, MAHA, neurological symptoms, renal dysfunction, fever.

• How to diagnose. ADAMTS13 activity under 10%, schistocytes on smear, elevated LDH, low haptoglobin, negative Coombs.

• Common misdiagnoses. DIC, HUS, Evans syndrome, ITP, preeclampsia/HELLP, malignant hypertension.

• How to prevent diagnostic errors. Schistocytes + thrombocytopenia + elevated LDH = TTP emergency; check ADAMTS13 before plasma exchange.

• Medical treatment. Plasma exchange (emergency); corticosteroids; rituximab; caplacizumab.

• Natural/lifestyle treatment. Folic acid supplementation.

• Drugs that worsen. Do NOT transfuse platelets (can worsen thrombosis).

• Food effects. No specific food effects.

• Harms to self. Stroke, renal failure, cardiac ischemia, death if untreated (90% mortality without treatment).

• Harms to others. None directly.

• Can it be overcome? Excellent survival with plasma exchange; caplacizumab reduces time to remission.

56. Autoimmune Hypophysitis

• What it is. Immune attack on pituitary gland; increasingly common with checkpoint inhibitor therapy.

• Clinical presentation. Headache, fatigue, nausea, low blood pressure, visual field defects, multiple hormone deficiencies.

• How to diagnose. Pituitary hormone panel, MRI pituitary (symmetric enlargement), cosyntropin stimulation test.

• Common misdiagnoses. Pituitary adenoma, craniopharyngioma, metastatic disease, sarcoidosis.

• How to prevent diagnostic errors. In cancer patients on immunotherapy, fatigue + nausea + hyponatremia = check morning cortisol urgently.

• Medical treatment. Hydrocortisone replacement (start BEFORE levothyroxine); testosterone; levothyroxine; high-dose steroids for mass effect.

• Natural/lifestyle treatment. Stress dosing education; medical alert bracelet.

• Drugs that worsen. Checkpoint inhibitors (ipilimumab > nivolumab/pembrolizumab).

• Food effects. No specific food effects.

• Harms to self. Adrenal crisis (fatal), permanent hormone deficiency.

• Harms to others. None directly.

• Can it be overcome? ACTH deficiency usually permanent; other axes may recover.

57. Lambert-Eaton Myasthenic Syndrome

• What it is. Antibodies against P/Q-type VGCCs at presynaptic neuromuscular junction; 50-60% paraneoplastic (SCLC).

• Clinical presentation. Proximal leg weakness, reduced reflexes that improve after exercise, dry mouth, constipation, erectile dysfunction.

• How to diagnose. Anti-VGCC antibodies, EMG (low CMAPs, increment over 100% post-exercise), CT chest for SCLC.

• Common misdiagnoses. Myasthenia gravis, neuropathy, deconditioning, polymyositis.

• How to prevent diagnostic errors. Leg-predominant weakness + absent reflexes + dry mouth + smoking history = LEMS; use DELTA-P score; screen for SCLC.

• Medical treatment. Amifampridine (first-line); IVIG; corticosteroids; immunosuppressants; treat underlying cancer.

• Natural/lifestyle treatment. Smoking cessation (critical); exercise.

• Drugs that worsen. Aminoglycosides, magnesium, calcium channel blockers.

• Food effects. No specific food effects.

• Harms to self. Respiratory failure, cancer progression.

• Harms to others. None directly.

• Can it be overcome? Paraneoplastic form may improve with cancer treatment; autoimmune form responds to immunotherapy.

58. Autoimmune Autonomic Ganglionopathy

• What it is. Antibodies against ganglionic AChR causing widespread autonomic failure.

• Clinical presentation. Orthostatic hypotension, anhidrosis, GI dysmotility, urinary retention, erectile dysfunction, sluggish pupils.

• How to diagnose. Ganglionic AChR antibodies, tilt table test, QSART, Valsalva maneuver.

• Common misdiagnoses. Diabetic autonomic neuropathy, Parkinson's, pure autonomic failure, anxiety, deconditioning.

• How to prevent diagnostic errors. Orthostatic hypotension + GI dysmotility + dry eyes + ED in previously healthy person = suspect AAG.

• Medical treatment. IVIG; corticosteroids; plasma exchange; rituximab; midodrine/droxidopa for orthostatic hypotension.

• Natural/lifestyle treatment. Compression stockings; increased salt/fluid intake; small frequent meals.

• Drugs that worsen. Anticholinergics, diuretics, vasodilators (worsen orthostatic hypotension).

• Food effects. Increased salt and fluid intake helps.

• Harms to self. Falls, syncope, malnutrition, severe disability.

• Harms to others. None directly.

• Can it be overcome? One-third improve spontaneously; immunotherapy helps many; recovery often incomplete.

59. Microscopic Colitis

• What it is. Inflammatory bowel disease with normal-appearing colon; diagnosis requires biopsy.

• Clinical presentation. Chronic watery non-bloody diarrhea, nocturnal bowel movements, fecal urgency, weight loss.

• How to diagnose. Colonoscopy with random biopsies (colon looks normal), histology (collagenous or lymphocytic pattern).

• Common misdiagnoses. IBS, celiac disease, bile acid malabsorption, lactose intolerance, medication side effect.

• How to prevent diagnostic errors. Normal colonoscopy does NOT exclude microscopic colitis; always biopsy if chronic watery diarrhea.

• Medical treatment. Budesonide (first-line, 80-88% response); stop offending medications; cholestyramine; vedolizumab.

• Natural/lifestyle treatment. Identify and stop trigger medications; stress management.

• Drugs that worsen. NSAIDs, PPIs, SSRIs, statins (common triggers).

• Food effects. Avoid trigger foods; adequate hydration.

• Harms to self. Dehydration, weight loss, reduced quality of life.

• Harms to others. None directly.

• Can it be overcome? Budesonide highly effective; relapse common after stopping.

60. Cold Agglutinin Disease

• What it is. IgM autoantibodies cause complement-mediated hemolysis at cold temperatures; clonal B-cell disorder.

• Clinical presentation. Chronic anemia, cold-induced acrocyanosis/Raynaud's, jaundice, hemolytic crises with cold exposure.

• How to diagnose. DAT (C3d positive, IgG negative), cold agglutinin titer, monoclonal IgM, LDH elevated.

• Common misdiagnoses. Warm AIHA, cryoglobulinemia, Raynaud's disease, PNH.

• How to prevent diagnostic errors. C3d-positive/IgG-negative DAT distinguishes from warm AIHA; cold agglutinins interfere with automated CBC.

• Medical treatment. Sutimlimab (anti-C1s, FDA-approved); rituximab +/- bendamustine; corticosteroids NOT effective.

• Natural/lifestyle treatment. Avoid cold exposure; warm clothing; warm blood before transfusion.

• Drugs that worsen. Corticosteroids (ineffective), splenectomy (ineffective, unlike warm AIHA).

• Food effects. No specific food effects.

• Harms to self. Severe anemia, thrombosis, acrocyanosis, gangrene (rare).

• Harms to others. None directly.

• Can it be overcome? Sutimlimab is a major advance; rituximab effective.

61. Schnitzler Syndrome

• What it is. Chronic urticarial rash + monoclonal IgM gammopathy + systemic inflammation; rare.

• Clinical presentation. Non-pruritic urticarial rash, recurrent fevers, bone pain, arthralgia, elevated CRP/ESR, lymphadenopathy.

• How to diagnose. Strasbourg criteria (urticaria + monoclonal IgM + 2 minor criteria), skin biopsy (neutrophilic), SPEP.

• Common misdiagnoses. Chronic spontaneous urticaria, adult-onset Still's disease, MGUS with coincidental urticaria, vasculitis.

• How to prevent diagnostic errors. Urticaria + monoclonal gammopathy + systemic inflammation + bone pain = Schnitzler.

• Medical treatment. Anakinra (IL-1 blockade, 95% response); canakinumab; colchicine for mild disease.

• Natural/lifestyle treatment. No specific natural treatments.

• Drugs that worsen. Corticosteroids not recommended for chronic use.

• Food effects. No specific food effects.

• Harms to self. Lymphoproliferative disease progression (10-15%), AA amyloidosis.

• Harms to others. None directly.

• Can it be overcome? Anakinra is dramatically effective; lifelong monitoring for lymphoma required.

62. VEXAS Syndrome

• What it is. Somatic UBA1 mutation; X-linked, predominantly men over 50; bridges rheumatology and hematology.

• Clinical presentation. Neutrophilic dermatoses, chondritis, recurrent fevers, VTE (40-50%), macrocytic anemia, thrombocytopenia.

• How to diagnose. UBA1 gene sequencing; bone marrow biopsy (cytoplasmic vacuoles in myeloid/erythroid precursors).

• Common misdiagnoses. Relapsing polychondritis, Sweet syndrome, MDS, PAN, adult-onset Still's disease, sarcoidosis.

• How to prevent diagnostic errors. Man over 50 with steroid-dependent inflammation + cytopenias + VTE = test for UBA1 mutation.

• Medical treatment. Glucocorticoids; JAK inhibitors (ruxolitinib); tocilizumab; azacitidine; allogeneic HSCT (potentially curative).

• Natural/lifestyle treatment. No specific natural treatments.

• Drugs that worsen. Rituximab generally ineffective; conventional DMARDs ineffective.

• Food effects. No specific food effects.

• Harms to self. Progressive bone marrow failure, VTE, infections, death (5-year mortality ~40%).

• Harms to others. X-linked somatic, not inherited.

• Can it be overcome? Potentially curative with allogeneic HSCT; otherwise chronic and progressive.

63. Paraneoplastic Cerebellar Degeneration

• What it is. Antibodies (anti-Yo, anti-Hu, anti-Tr) attack Purkinje cells; associated with underlying cancer.

• Clinical presentation. Rapidly progressive cerebellar ataxia, dysarthria, nystagmus, vertigo, inability to walk.

• How to diagnose. Anti-neuronal antibodies (anti-Yo, anti-Hu, anti-Tr, anti-VGCC), MRI brain, PET/CT for occult malignancy.

• Common misdiagnoses. Alcoholic cerebellar degeneration, MS, stroke, brain metastasis, vitamin deficiency.

• How to prevent diagnostic errors. Rapidly progressive ataxia in an adult = paraneoplastic until proven otherwise; search for cancer.

• Medical treatment. Treat underlying cancer; IVIG, corticosteroids, plasma exchange (limited efficacy once neurons destroyed).

• Natural/lifestyle treatment. Physical therapy; fall prevention; assistive devices.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Severe disability, permanent ataxia, death from underlying cancer.

• Harms to others. None directly.

• Can it be overcome? Neurological damage usually irreversible; prognosis depends on cancer treatment.

64. Idiopathic Multicentric Castleman Disease

• What it is. Cytokine-driven (IL-6) lymphoproliferative disorder; immune-mediated.

• Clinical presentation. Diffuse lymphadenopathy, fevers, night sweats, weight loss, hepatosplenomegaly, edema, cytopenias.

• How to diagnose. Lymph node biopsy, elevated IL-6, CRP, IgG; exclude lymphoma, HHV-8.

• Common misdiagnoses. Lymphoma, SLE, IgG4-RD, sarcoidosis, HIV-associated MCD, infections.

• How to prevent diagnostic errors. Biopsy is essential; must test for HHV-8 (HHV-8+ MCD requires different treatment).

• Medical treatment. Siltuximab (anti-IL-6, FDA-approved); tocilizumab; rituximab; corticosteroids; chemotherapy for refractory.

• Natural/lifestyle treatment. No specific natural treatments.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Organ failure, amyloidosis, lymphoma, death if untreated.

• Harms to others. None directly.

• Can it be overcome? Siltuximab achieves durable responses in many; some require long-term treatment.

65. Autoimmune Neutropenia (Adult)

• What it is. Antibodies destroy neutrophils causing low neutrophil count.

• Clinical presentation. Recurrent infections (skin, oral, respiratory), fever, mouth ulcers; often mild in adults.

• How to diagnose. ANC under 1500, anti-neutrophil antibodies (GIFT, MAIGA), bone marrow biopsy to exclude MDS.

• Common misdiagnoses. Drug-induced neutropenia, MDS, aplastic anemia, cyclic neutropenia, LGL leukemia.

• How to prevent diagnostic errors. If neutropenia is isolated and chronic, check anti-neutrophil antibodies; exclude LGL leukemia.

• Medical treatment. G-CSF for severe infections; corticosteroids; rituximab; treat underlying cause.

• Natural/lifestyle treatment. Infection prevention; good oral hygiene; avoid raw foods during severe neutropenia.

• Drugs that worsen. Clozapine, carbimazole, sulfasalazine (drug-induced neutropenia).

• Food effects. Avoid raw/undercooked foods during severe neutropenia.

• Harms to self. Severe infections, sepsis.

• Harms to others. None directly.

• Can it be overcome? Adult autoimmune neutropenia usually chronic but mild; childhood form often resolves.

66. Inclusion Body Myositis

• What it is. Inflammatory and degenerative muscle disease; most common acquired myopathy in men over 50.

• Clinical presentation. Asymmetric weakness of finger flexors and knee extensors (quadriceps), dysphagia, falls, slow progression.

• How to diagnose. CK (mildly elevated), anti-cN1A antibodies (30-60%), muscle biopsy (rimmed vacuoles), MRI.

• Common misdiagnoses. Polymyositis (most common misdiagnosis), motor neuron disease, muscular dystrophy, diabetic amyotrophy.

• How to prevent diagnostic errors. Finger flexor + quadriceps weakness pattern is distinctive; does NOT respond to immunosuppression (unlike PM).

• Medical treatment. No proven effective treatment; IVIG may help dysphagia; exercise; swallowing therapy.

• Natural/lifestyle treatment. Exercise (resistance training slows decline); fall prevention; swallowing strategies.

• Drugs that worsen. Corticosteroids NOT effective (cause steroid myopathy); immunosuppressants NOT effective.

• Food effects. Adequate protein intake to support muscle mass.

• Harms to self. Progressive disability, wheelchair dependence, aspiration pneumonia.

• Harms to others. None directly.

• Can it be overcome? Slowly progressive; no cure; exercise and supportive care are mainstays.

67. Adult-Onset Still's Disease

• What it is. Systemic autoinflammatory disease with quotidian fevers, rash, and arthritis.

• Clinical presentation. High spiking daily fevers, salmon-colored evanescent rash, arthritis, sore throat, lymphadenopathy, serositis.

• How to diagnose. Markedly elevated ferritin (often over 1000), low glycosylated ferritin (under 20%), elevated CRP/ESR.

• Common misdiagnoses. Infection (sepsis), lymphoma, SLE, vasculitis, reactive arthritis, hemophagocytic lymphohistiocytosis.

• How to prevent diagnostic errors. Ferritin over 1000 + quotidian fevers + evanescent rash = AOSD; low glycosylated ferritin is highly specific.

• Medical treatment. NSAIDs; corticosteroids; anakinra/canakinumab (IL-1); tocilizumab (IL-6); methotrexate.

• Natural/lifestyle treatment. Stress management; adequate rest during flares.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Macrophage activation syndrome (life-threatening), joint destruction, amyloidosis.

• Harms to others. None directly.

• Can it be overcome? Many achieve remission; some have chronic relapsing course; IL-1 blockade highly effective.

68. Paraneoplastic Syndromes (Testicular Cancer-Associated)

• What it is. Immune responses triggered by testicular germ cell tumors causing neurological/systemic disease.

• Clinical presentation. Anti-NMDAR encephalitis (with teratoma), limbic encephalitis, cerebellar degeneration, dermatomyositis.

• How to diagnose. Tumor markers (AFP, beta-hCG, LDH), anti-neuronal antibodies (anti-Ma2, anti-KLHL11), testicular ultrasound, CT/PET.

• Common misdiagnoses. Primary psychiatric disease, viral encephalitis, autoimmune encephalitis, epilepsy.

• How to prevent diagnostic errors. Young man with new neuropsychiatric symptoms = check testicular ultrasound and tumor markers; consider orchiectomy if microcalcifications.

• Medical treatment. Orchiectomy (tumor removal); immunotherapy (IVIG, corticosteroids, rituximab, plasma exchange).

• Natural/lifestyle treatment. Testicular self-examination; cancer surveillance.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Neurological disability, cancer progression.

• Harms to others. None directly.

• Can it be overcome? Often improves dramatically after tumor removal; early detection is key.

69. Morphea (Localized Scleroderma)

• What it is. Autoimmune inflammatory and fibrotic disorder of skin and underlying tissue; distinct from systemic sclerosis.

• Clinical presentation. Oval patches of thickened waxy skin with violaceous border, linear bands on limbs or face, joint contractures.

• How to diagnose. Clinical appearance, skin biopsy (dermal sclerosis), MRI for depth, ANA (40-70% positive).

• Common misdiagnoses. Systemic sclerosis, lichen sclerosus, radiation dermatitis, lipodermatosclerosis, panniculitis.

• How to prevent diagnostic errors. No Raynaud's, no sclerodactyly, no nailfold capillary changes = morphea, not systemic sclerosis.

• Medical treatment. Topical steroids (limited); UVA1 phototherapy; methotrexate + corticosteroids (linear/generalized); mycophenolate.

• Natural/lifestyle treatment. Physical therapy (essential for linear morphea crossing joints); moisturizers.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Joint contractures, limb length discrepancy (children), cosmetic disfigurement.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Most respond to treatment; linear morphea may cause permanent contractures if untreated.

70. Lichen Sclerosus (Male Genital)

• What it is. Chronic autoimmune inflammatory skin disease primarily affecting foreskin and glans penis.

• Clinical presentation. White atrophic sclerotic patches on foreskin/glans, phimosis, painful erections, meatal stenosis, weak urine stream.

• How to diagnose. Clinical appearance (white sclerotic patches), biopsy if uncertain or malignancy suspected.

• Common misdiagnoses. Fungal infection (candidiasis), poor hygiene, eczema, penile cancer, contact dermatitis.

• How to prevent diagnostic errors. Any man with progressive phimosis or white patches on glans should be evaluated; not just aging.

• Medical treatment. Clobetasol 0.05% (first-line); tacrolimus; circumcision (curative for foreskin disease); meatotomy/urethroplasty.

• Natural/lifestyle treatment. Gentle hygiene; emollients; regular self-examination for changes.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Penile squamous cell carcinoma (2-8% risk), urethral strictures, sexual dysfunction.

• Harms to others. None directly.

• Can it be overcome? Topical steroids effective in 50-70%; circumcision curative for foreskin disease.

71. Lichen Planus

• What it is. T-cell mediated inflammatory disease of skin, oral mucosa, genitals, scalp, and nails.

• Clinical presentation. Purple polygonal pruritic papules (flexor wrists), oral white lacy patches, genital erosions, scarring alopecia.

• How to diagnose. Clinical appearance, biopsy (band-like lymphocytic infiltrate), DIF (fibrinogen band), test for hepatitis C.

• Common misdiagnoses. Psoriasis, oral leukoplakia, oral candidiasis, lupus, secondary syphilis, drug eruption.

• How to prevent diagnostic errors. Bilateral reticular white patches on buccal mucosa are classic; always test for hepatitis C.

• Medical treatment. Topical corticosteroids; tacrolimus; acitretin; hydroxychloroquine; methotrexate; phototherapy.

• Natural/lifestyle treatment. Gentle oral care; avoid spicy/acidic foods for oral disease; stress management.

• Drugs that worsen. ACE inhibitors, beta-blockers, NSAIDs, antimalarials (drug-induced lichenoid eruption).

• Food effects. Avoid spicy and acidic foods for oral lichen planus.

• Harms to self. Oral squamous cell carcinoma (1-2% risk), scarring alopecia, nail destruction.

• Harms to others. None directly.

• Can it be overcome? Cutaneous LP often self-limited (1-2 years); oral LP is chronic; malignancy surveillance needed.

72. Pemphigus Foliaceus

• What it is. Autoantibodies against desmoglein 1 causing superficial skin blistering; NO mucosal involvement.

• Clinical presentation. Crusted scaly erosions on scalp, face, chest, upper back (seborrheic distribution); blisters rarely seen intact.

• How to diagnose. Skin biopsy with DIF (intercellular IgG in superficial epidermis), anti-Dsg1 positive, anti-Dsg3 negative.

• Common misdiagnoses. Eczema, psoriasis, seborrheic dermatitis, impetigo, drug eruption.

• How to prevent diagnostic errors. No oral involvement distinguishes from pemphigus vulgaris; superficial crusting rather than deep erosions.

• Medical treatment. Rituximab; corticosteroids; mycophenolate; azathioprine; dapsone; topical steroids for mild.

• Natural/lifestyle treatment. Gentle skin care; sun protection; wound care.

• Drugs that worsen. D-penicillamine, captopril, rifampin (drug-induced pemphigus).

• Food effects. No specific food effects.

• Harms to self. Secondary infection, fluid loss (severe cases).

• Harms to others. None directly.

• Can it be overcome? Often less severe than pemphigus vulgaris; rituximab effective.

73. Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)

• What it is. Autoimmune blistering disease primarily affecting mucous membranes; heals with scarring.

• Clinical presentation. Oral erosions, desquamative gingivitis, ocular inflammation/scarring (symblepharon), nasal/laryngeal/genital involvement.

• How to diagnose. Biopsy with DIF (linear IgG/IgA/C3 at BMZ), anti-BP180, anti-laminin-332 (cancer risk).

• Common misdiagnoses. Aphthous ulcers, lichen planus, chronic conjunctivitis, pemphigus vulgaris, Stevens-Johnson syndrome.

• How to prevent diagnostic errors. Scarring of mucous membranes at multiple sites is the key clue; ophthalmology exam mandatory.

• Medical treatment. Dapsone (mild); mycophenolate/azathioprine (moderate); cyclophosphamide/rituximab (severe/ocular).

• Natural/lifestyle treatment. Gentle oral care; eye lubrication.

• Drugs that worsen. None specific.

• Food effects. Soft non-irritating foods for oral disease.

• Harms to self. Blindness (ocular scarring), airway stenosis, esophageal stricture.

• Harms to others. None directly.

• Can it be overcome? Ocular disease can cause blindness if untreated; early aggressive treatment for eye involvement critical.

74. Multifocal Motor Neuropathy

• What it is. Acquired immune-mediated purely motor neuropathy; more common in men (2.6:1).

• Clinical presentation. Asymmetric distal upper extremity weakness (wrist drop, grip weakness), no sensory loss, slow progression.

• How to diagnose. NCS (motor conduction block), anti-GM1 IgM antibodies (40-50%), nerve ultrasound.

• Common misdiagnoses. ALS (most critical misdiagnosis), cervical radiculopathy, CIDP, mononeuropathy.

• How to prevent diagnostic errors. Unlike ALS: no UMN signs, no bulbar involvement, conduction block on NCS, responds to IVIG.

• Medical treatment. IVIG (first-line, 80% response); subcutaneous immunoglobulin; NOT corticosteroids or plasma exchange.

• Natural/lifestyle treatment. Exercise; occupational therapy; adaptive devices.

• Drugs that worsen. Corticosteroids (can worsen MMN), plasma exchange (can worsen).

• Food effects. No specific food effects.

• Harms to self. Progressive weakness, disability, muscle atrophy.

• Harms to others. None directly.

• Can it be overcome? IVIG is highly effective; most maintain function with ongoing treatment.

75. Anti-MAG Neuropathy

• What it is. IgM antibodies against myelin-associated glycoprotein causing chronic demyelinating neuropathy.

• Clinical presentation. Slowly progressive distal sensory neuropathy, gait ataxia, tremor, numbness/tingling (legs first).

• How to diagnose. Anti-MAG antibodies (IgM), SPEP/immunofixation (IgM monoclonal protein), NCS (prolonged distal latencies).

• Common misdiagnoses. CIDP, diabetic neuropathy, hereditary neuropathy (CMT), B12 deficiency neuropathy.

• How to prevent diagnostic errors. Disproportionately prolonged distal motor latencies on NCS are characteristic; check for IgM monoclonal protein.

• Medical treatment. Rituximab (preferred first-line); IVIG (limited efficacy); treat underlying lymphoproliferative disease.

• Natural/lifestyle treatment. Exercise; balance training; fall prevention; assistive devices.

• Drugs that worsen. Corticosteroids (generally ineffective).

• Food effects. No specific food effects.

• Harms to self. Progressive ataxia, disability, falls.

• Harms to others. None directly.

• Can it be overcome? Slowly progressive despite treatment; rituximab may stabilize.

76. POEMS Syndrome

• What it is. Paraneoplastic syndrome from clonal plasma cell disorder; Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin.

• Clinical presentation. Progressive symmetric demyelinating neuropathy, hepatosplenomegaly, hypogonadism, sclerotic bone lesions, skin hyperpigmentation, edema.

• How to diagnose. VEGF (markedly elevated), monoclonal protein (lambda light chain), skeletal survey/PET-CT, bone marrow biopsy.

• Common misdiagnoses. CIDP (most common misdiagnosis, treated with IVIG for years), myeloma, amyloidosis.

• How to prevent diagnostic errors. Any CIDP not responding to standard therapy = check VEGF and screen for POEMS; IVIG does NOT work for POEMS.

• Medical treatment. Radiation (localized disease); autologous HSCT (disseminated); lenalidomide + dexamethasone.

• Natural/lifestyle treatment. Exercise; physical therapy; endocrine hormone replacement.

• Drugs that worsen. IVIG NOT effective; corticosteroids alone NOT effective; plasma exchange NOT effective.

• Food effects. No specific food effects.

• Harms to self. Progressive neuropathy, organ failure, death if untreated.

• Harms to others. None directly.

• Can it be overcome? Radiation can be curative for localized disease; HSCT effective for disseminated.

77. Paroxysmal Nocturnal Hemoglobinuria (PNH)

• What it is. Acquired complement-mediated hemolytic anemia from somatic PIGA gene mutation.

• Clinical presentation. Hemolytic anemia, dark/red morning urine, thrombosis in unusual sites (hepatic, cerebral veins), fatigue, erectile dysfunction.

• How to diagnose. Flow cytometry (absent CD55/CD59 on RBCs and granulocytes), elevated LDH, low haptoglobin, negative Coombs.

• Common misdiagnoses. Iron deficiency anemia, warm AIHA, aplastic anemia, unexplained thrombosis, MDS.

• How to prevent diagnostic errors. Coombs-negative hemolysis + unusual site thrombosis = screen with flow cytometry.

• Medical treatment. Eculizumab/ravulizumab (anti-C5); iptacopan (oral factor B); pegcetacoplan (C3); allogeneic HSCT (curative).

• Natural/lifestyle treatment. Meningococcal vaccination (mandatory); iron/folate supplementation.

• Drugs that worsen. Avoid complement inhibitors without meningococcal vaccination.

• Food effects. No specific food effects.

• Harms to self. Thrombosis (leading cause of death), bone marrow failure, renal damage.

• Harms to others. None directly.

• Can it be overcome? Complement inhibitors have transformed prognosis; HSCT is only cure.

78. Autoimmune Atrophic Gastritis

• What it is. Immune destruction of gastric parietal cells causing achlorhydria; underlies pernicious anemia.

• Clinical presentation. Iron deficiency anemia (early), dyspepsia, bloating; later B12 deficiency, macrocytic anemia, neurological symptoms.

• How to diagnose. Anti-parietal cell antibodies, anti-IF antibodies, elevated gastrin, low pepsinogen I, endoscopy with gastric biopsies.

• Common misdiagnoses. Iron deficiency from GI bleeding, H. pylori gastritis, GERD, functional dyspepsia, gastric cancer.

• How to prevent diagnostic errors. Iron deficiency in a man with no bleeding source should prompt evaluation for autoimmune atrophic gastritis.

• Medical treatment. Iron supplementation (often IV); B12 supplementation; endoscopic surveillance every 3 years.

• Natural/lifestyle treatment. Adequate iron and B12 intake; avoid PPIs if possible.

• Drugs that worsen. PPIs (worsen acid suppression and may accelerate atrophy).

• Food effects. B12-rich and iron-rich foods help; vitamin C enhances iron absorption.

• Harms to self. Gastric neuroendocrine tumors, gastric adenocarcinoma, micronutrient deficiencies.

• Harms to others. None directly.

• Can it be overcome? Not reversible; lifelong supplementation and cancer surveillance required.

79. Sympathetic Ophthalmia

• What it is. Bilateral granulomatous panuveitis after penetrating trauma or surgery to one eye.

• Clinical presentation. Uninjured eye develops uveitis (blurred vision, photophobia, pain, floaters), Dalen-Fuchs nodules.

• How to diagnose. Clinical history (penetrating ocular trauma/surgery) + bilateral granulomatous uveitis, OCT, fluorescein angiography.

• Common misdiagnoses. Sarcoidosis, VKH, tuberculosis, syphilis, lymphoma.

• How to prevent diagnostic errors. History of penetrating eye trauma + bilateral uveitis = sympathetic ophthalmia until proven otherwise.

• Medical treatment. High-dose systemic corticosteroids (urgent); mycophenolate; azathioprine; cyclosporine; adalimumab.

• Natural/lifestyle treatment. Sun protection; stress management.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Blindness in both eyes if untreated.

• Harms to others. None directly.

• Can it be overcome? Early aggressive treatment can preserve vision; delayed treatment leads to poor outcomes.

80. Mooren Ulcer

• What it is. Autoimmune peripheral ulcerative keratitis with no systemic disease; more common in men.

• Clinical presentation. Painful progressive peripheral corneal ulceration starting at limbus, advancing centrally; can perforate.

• How to diagnose. Slit-lamp exam (peripheral ulcer with overhanging edge); diagnosis of exclusion (rule out RA, GPA, PAN).

• Common misdiagnoses. RA-associated PUK, GPA, infectious keratitis, Terrien marginal degeneration.

• How to prevent diagnostic errors. Must exclude systemic autoimmune diseases and infections; Mooren is a diagnosis of exclusion.

• Medical treatment. Topical corticosteroids/cyclosporine; conjunctival resection; systemic immunosuppression; corneal transplant.

• Natural/lifestyle treatment. Eye protection; avoid trauma.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Corneal perforation, vision loss.

• Harms to others. None directly.

• Can it be overcome? Unilateral form has better prognosis; bilateral form is aggressive.

81. Eosinophilic Fasciitis (Shulman Syndrome)

• What it is. Autoimmune inflammation and thickening of deep fascia; more common in men (~70%); often triggered by exertion.

• Clinical presentation. Acute painful swelling and induration of extremities (sparing hands/feet), peau d'orange texture, groove sign, joint contractures.

• How to diagnose. Full-thickness biopsy (skin through fascia), MRI (fascial thickening), eosinophilia, elevated aldolase.

• Common misdiagnoses. Systemic sclerosis, DVT, cellulitis, lipodermatosclerosis, nephrogenic systemic fibrosis.

• How to prevent diagnostic errors. Spares hands and feet (unlike scleroderma); aldolase more sensitive than CK for fascial inflammation.

• Medical treatment. Corticosteroids (first-line); methotrexate (steroid-sparing); mycophenolate; tocilizumab; rituximab.

• Natural/lifestyle treatment. Physical therapy (essential to prevent contractures); gentle stretching.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Joint contractures, aplastic anemia (rare), MDS/lymphoma (rare association).

• Harms to others. None directly.

• Can it be overcome? Most respond well to treatment; relapse possible; physical therapy critical.

82. C3 Glomerulopathy

• What it is. Complement-mediated kidney disease from alternative pathway dysregulation; includes DDD and C3GN.

• Clinical presentation. Hematuria, proteinuria, hypertension, progressive kidney failure; DDD has lipodystrophy and retinal drusen.

• How to diagnose. Kidney biopsy (dominant C3 on IF, minimal Ig), electron microscopy, complement studies, genetic testing.

• Common misdiagnoses. IgA nephropathy, membranoproliferative GN, lupus nephritis, post-infectious GN.

• How to prevent diagnostic errors. Dominant C3 staining without immunoglobulin on IF is the key biopsy finding.

• Medical treatment. Supportive (ACE/ARBs, SGLT2 inhibitors); pegcetacoplan/iptacopan (complement inhibitors); mycophenolate.

• Natural/lifestyle treatment. Low-sodium diet; blood pressure control; adequate hydration.

• Drugs that worsen. NSAIDs worsen kidney function.

• Food effects. Low-sodium diet.

• Harms to self. End-stage kidney disease (50% in 10 years), high recurrence after transplant.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Complement inhibitors are a major advance; transplant complicated by recurrence.

83. Autoimmune Hypoparathyroidism

• What it is. Immune destruction of parathyroid glands; usually part of APS-1 (AIRE gene mutation).

• Clinical presentation. Muscle cramps, perioral/fingertip tingling, tetany, seizures, laryngospasm, prolonged QT, cataracts.

• How to diagnose. Low calcium, high phosphorus, low/inappropriately normal PTH, anti-NALP5 antibodies, AIRE gene testing.

• Common misdiagnoses. Hypomagnesemia, vitamin D deficiency, post-surgical hypoparathyroidism, pseudohypoparathyroidism.

• How to prevent diagnostic errors. Chvostek and Trousseau signs are classic; check calcium in any patient with tetany or seizures.

• Medical treatment. Calcium + calcitriol; recombinant PTH (teriparatide); thiazide diuretics (reduce urinary calcium).

• Natural/lifestyle treatment. Calcium-rich foods; vitamin D; avoid phosphate-rich foods.

• Drugs that worsen. Loop diuretics (increase calcium excretion); bisphosphonates.

• Food effects. Calcium-rich foods help; phosphate-rich foods worsen.

• Harms to self. Kidney stones, nephrocalcinosis, seizures, cardiac arrhythmia, cataracts.

• Harms to others. Genetic susceptibility (APS-1).

• Can it be overcome? Not curable; lifelong calcium and calcitriol replacement.

84. IPEX Syndrome

• What it is. X-linked FOXP3 mutation causing Treg deficiency; almost exclusively affects males; presents in infancy.

• Clinical presentation. Severe intractable diarrhea (autoimmune enteropathy), neonatal type 1 diabetes, severe eczema, autoimmune cytopenias.

• How to diagnose. FOXP3 gene sequencing, flow cytometry (absent/dysfunctional Tregs), elevated IgE, eosinophilia.

• Common misdiagnoses. Severe combined immunodeficiency, food protein enteropathy, neonatal sepsis, congenital CMV.

• How to prevent diagnostic errors. Male infant with intractable diarrhea + neonatal diabetes + severe eczema = test FOXP3 urgently.

• Medical treatment. Allogeneic HSCT (only cure); sirolimus (preferred over calcineurin inhibitors); supportive care.

• Natural/lifestyle treatment. Nutritional support; infection prevention.

• Drugs that worsen. Calcineurin inhibitors (suppress already-deficient Tregs).

• Food effects. No specific food effects.

• Harms to self. Multi-organ failure, death in first 1-2 years without HSCT.

• Harms to others. X-linked (carrier mothers can pass to sons).

• Can it be overcome? Curative with early HSCT; gene therapy under investigation.

85. Dermatitis Herpetiformis

• What it is. Cutaneous manifestation of celiac disease; IgA deposits in skin; more common in men (2:1).

• Clinical presentation. Intensely pruritic grouped vesicles and papules on elbows, knees, buttocks, scalp; often excoriated.

• How to diagnose. Skin biopsy with DIF (granular IgA at dermal papillae), tTG-IgA, small bowel biopsy.

• Common misdiagnoses. Eczema, scabies, contact dermatitis, linear IgA bullous dermatosis, bullous pemphigoid.

• How to prevent diagnostic errors. Granular IgA (not linear) on DIF is pathognomonic; always screen for celiac disease.

• Medical treatment. Dapsone (rapid symptom relief within 24-48 hours); strict gluten-free diet (treats underlying cause).

• Natural/lifestyle treatment. Strict gluten-free diet (essential); iodine restriction may help.

• Drugs that worsen. Iodine-containing medications (can trigger flares).

• Food effects. Gluten must be strictly avoided; high-iodine foods may worsen.

• Harms to self. Intestinal lymphoma (if celiac untreated), osteoporosis, nutritional deficiencies.

• Harms to others. Genetic susceptibility (HLA-DQ2/DQ8).

• Can it be overcome? Gluten-free diet can eliminate skin disease entirely.

86. Paraneoplastic Pemphigus

• What it is. Autoantibodies against multiple desmosomal proteins; always associated with underlying neoplasm.

• Clinical presentation. Severe, painful, treatment-resistant oral erosions, polymorphous skin lesions, bronchiolitis obliterans.

• How to diagnose. Skin biopsy with DIF (intercellular + BMZ staining), anti-envoplakin/periplakin antibodies, CT for malignancy.

• Common misdiagnoses. Pemphigus vulgaris, erythema multiforme, Stevens-Johnson syndrome, lichen planus, GVHD.

• How to prevent diagnostic errors. Oral erosions + polymorphous skin lesions + underlying lymphoproliferative disease = paraneoplastic pemphigus.

• Medical treatment. Treat underlying malignancy; rituximab; corticosteroids; IVIG; cyclophosphamide.

• Natural/lifestyle treatment. No specific natural treatments.

• Drugs that worsen. None specific.

• Food effects. Soft non-irritating foods for oral disease.

• Harms to self. Bronchiolitis obliterans (often fatal), sepsis, respiratory failure; mortality ~90% at 2 years.

• Harms to others. None directly.

• Can it be overcome? Worst prognosis of all pemphigus variants; bronchiolitis obliterans is leading cause of death.

87. Immune-Mediated Necrotizing Myopathy

• What it is. Autoantibodies (anti-HMGCR or anti-SRP) cause muscle fiber necrosis; anti-HMGCR often statin-triggered.

• Clinical presentation. Severe proximal weakness, markedly elevated CK (often over 10,000), dysphagia.

• How to diagnose. CK very high, anti-HMGCR or anti-SRP antibodies, muscle biopsy (necrosis with minimal inflammation), MRI.

• Common misdiagnoses. Statin myopathy (simple), polymyositis, dermatomyositis, muscular dystrophy, rhabdomyolysis.

• How to prevent diagnostic errors. Weakness persisting or worsening after statin discontinuation + very high CK = check anti-HMGCR.

• Medical treatment. IVIG; corticosteroids; rituximab; methotrexate; mycophenolate; statins permanently discontinued.

• Natural/lifestyle treatment. Exercise (after disease control); physical therapy.

• Drugs that worsen. Statins (trigger anti-HMGCR IMNM; must be permanently discontinued).

• Food effects. Red yeast rice contains lovastatin and should be avoided.

• Harms to self. Severe disability, respiratory failure, cardiac involvement (anti-SRP).

• Harms to others. None directly.

• Can it be overcome? Most respond to aggressive immunotherapy; anti-SRP has worse prognosis than anti-HMGCR.

88. Antisynthetase Syndrome

• What it is. Autoantibodies against aminoacyl-tRNA synthetases causing myositis, ILD, and arthritis.

• Clinical presentation. Myositis (proximal weakness), interstitial lung disease, non-erosive arthritis, mechanic's hands, Raynaud's, fever.

• How to diagnose. Myositis-specific antibodies (anti-Jo-1 most common, also anti-PL-7, anti-PL-12, anti-EJ, anti-OJ), CK, HRCT, PFTs.

• Common misdiagnoses. Dermatomyositis, polymyositis, RA with ILD, idiopathic pulmonary fibrosis, scleroderma.

• How to prevent diagnostic errors. Mechanic's hands + myositis + ILD = antisynthetase syndrome; anti-Jo-1 most common.

• Medical treatment. Corticosteroids; mycophenolate; azathioprine; rituximab; tacrolimus; ILD often drives treatment.

• Natural/lifestyle treatment. Smoking cessation; pulmonary rehabilitation; exercise (after disease control).

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Progressive ILD (leading cause of death), severe disability from myositis.

• Harms to others. None directly.

• Can it be overcome? ILD determines prognosis; early aggressive treatment improves outcomes; anti-Jo-1 better prognosis.

89. Rasmussen Encephalitis

• What it is. Chronic unilateral brain inflammation causing intractable seizures and progressive hemispheric atrophy.

• Clinical presentation. Intractable focal seizures (epilepsia partialis continua), progressive hemiparesis, cognitive decline, hemianopia.

• How to diagnose. MRI (progressive unilateral hemispheric atrophy), EEG, brain biopsy (T-cell infiltrate).

• Common misdiagnoses. Focal epilepsy, brain tumor, focal cortical dysplasia, CNS vasculitis, mitochondrial disease.

• How to prevent diagnostic errors. Intractable unilateral seizures + progressive unilateral brain atrophy on MRI = Rasmussen; always unilateral.

• Medical treatment. Hemispherectomy (definitive treatment); IVIG; corticosteroids; rituximab; tacrolimus.

• Natural/lifestyle treatment. Seizure safety precautions; cognitive rehabilitation; occupational therapy.

• Drugs that worsen. None specific.

• Food effects. Ketogenic diet may help seizure control.

• Harms to self. Severe disability, hemiplegia, cognitive impairment, intractable epilepsy.

• Harms to others. None directly.

• Can it be overcome? Hemispherectomy controls seizures but causes permanent hemiplegia.

90. Opsoclonus-Myoclonus Syndrome

• What it is. Autoimmune attack on cerebellum and brainstem; paraneoplastic or post-infectious.

• Clinical presentation. Opsoclonus (chaotic eye movements), myoclonus (sudden jerking), cerebellar ataxia, irritability, sleep disturbance.

• How to diagnose. Clinical recognition of opsoclonus + myoclonus, anti-neuronal antibodies, PET/CT for occult malignancy.

• Common misdiagnoses. Cerebellar ataxia from other causes, myoclonic epilepsy, viral cerebellitis, drug toxicity.

• How to prevent diagnostic errors. Chaotic eye movements + myoclonus = OMS; always search for underlying tumor, especially in adults.

• Medical treatment. Treat underlying tumor; IVIG; corticosteroids; rituximab; cyclophosphamide; plasma exchange.

• Natural/lifestyle treatment. Stress management; physical therapy; occupational therapy; cognitive rehabilitation.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Chronic cognitive and behavioral deficits, ataxia, disability.

• Harms to others. None directly.

• Can it be overcome? Paraneoplastic form may improve with tumor treatment; relapses common.

91. Acquired Hemophilia A

• What it is. Autoantibodies (inhibitors) against factor VIII causing severe bleeding; peak in elderly men.

• Clinical presentation. Sudden onset of severe bruising, soft tissue bleeding, muscle hematomas, retroperitoneal hemorrhage; NO joint bleeding.

• How to diagnose. Prolonged aPTT (not corrected by mixing study), low factor VIII activity, positive Bethesda assay.

• Common misdiagnoses. Congenital hemophilia (but no prior history), DIC, anticoagulant overdose, liver disease, vWD.

• How to prevent diagnostic errors. Isolated prolonged aPTT in elderly man with new severe bruising = check mixing study and factor VIII level.

• Medical treatment. Bypassing agents (rFVIIa, FEIBA) for acute bleeding; immunosuppression: corticosteroids + cyclophosphamide or rituximab.

• Natural/lifestyle treatment. Avoid trauma; avoid IM injections; medical alert bracelet.

• Drugs that worsen. Anticoagulants, antiplatelet agents increase bleeding risk; checkpoint inhibitors can trigger.

• Food effects. No specific food effects.

• Harms to self. Fatal hemorrhage (mortality 8-22%), compartment syndrome, retroperitoneal hemorrhage.

• Harms to others. None directly.

• Can it be overcome? Most eradicate inhibitor with immunosuppression (70-80%); mortality significant if delayed.

92. Autoimmune Pure Red Cell Aplasia

• What it is. Antibodies or T-cells selectively destroy RBC precursors; associated with thymoma, CLL, parvovirus B19.

• Clinical presentation. Severe anemia (fatigue, pallor, dyspnea) with normal WBC and platelets; gradual onset.

• How to diagnose. Severe normocytic anemia, reticulocyte count near zero, bone marrow biopsy, CT chest for thymoma.

• Common misdiagnoses. Iron deficiency anemia, B12/folate deficiency, aplastic anemia, MDS, anemia of chronic disease.

• How to prevent diagnostic errors. Isolated severe anemia + absent reticulocytes + normal WBC/platelets = PRCA; check for thymoma.

• Medical treatment. Thymectomy (if thymoma); corticosteroids; cyclosporine; cyclophosphamide; IVIG (parvovirus); rituximab.

• Natural/lifestyle treatment. Transfusion support as needed; iron chelation if transfusion-dependent.

• Drugs that worsen. Erythropoietin (can cause anti-EPO antibody-mediated PRCA); checkpoint inhibitors.

• Food effects. Adequate iron, B12, and folate intake.

• Harms to self. Transfusion dependence, iron overload, cardiovascular complications.

• Harms to others. None directly.

• Can it be overcome? Thymoma-associated PRCA often improves after thymectomy; cyclosporine effective in 65-75%.

93. Reactive Arthritis (formerly Reiter Syndrome)

• What it is. Post-infectious autoimmune arthritis triggered by GI or GU infections; more common in HLA-B27+ men.

• Clinical presentation. Asymmetric oligoarthritis (knees, ankles), enthesitis, urethritis, conjunctivitis/uveitis, circinate balanitis, dactylitis.

• How to diagnose. Clinical diagnosis; HLA-B27 (60-80% positive); stool/urine cultures; elevated CRP/ESR; joint aspiration to exclude septic arthritis.

• Common misdiagnoses. Gonococcal arthritis, psoriatic arthritis, ankylosing spondylitis, gout, septic arthritis, RA.

• How to prevent diagnostic errors. Asymmetric lower extremity arthritis in a young man after diarrhea or urethritis = reactive arthritis; test for Chlamydia.

• Medical treatment. NSAIDs (first-line); intra-articular corticosteroids; sulfasalazine; methotrexate; treat underlying Chlamydia; TNF inhibitors for refractory.

• Natural/lifestyle treatment. Exercise; physical therapy; safe sexual practices.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Chronic arthritis in 15-30%, sacroiliitis, aortic regurgitation (rare).

• Harms to others. Chlamydia can be sexually transmitted to partners.

• Can it be overcome? Most resolve within 3-12 months; 15-30% develop chronic disease.

94. Anti-IgLON5 Disease

• What it is. Rare autoimmune neurological disease with antibodies against IgLON5; associated with HLA-DRB1*10:01; brainstem-dominant tauopathy.

• Clinical presentation. Complex sleep disorder (insomnia, parasomnia, sleep-disordered breathing, stridor), gait instability, bulbar dysfunction, movement disorders, cognitive decline.

• How to diagnose. Anti-IgLON5 antibodies (serum and CSF), polysomnography (unique NREM/REM parasomnias), MRI brain, HLA typing.

• Common misdiagnoses. Progressive supranuclear palsy, Parkinson's disease, obstructive sleep apnea, ALS, multiple system atrophy.

• How to prevent diagnostic errors. Chronic progressive sleep disorder + gait instability + bulbar symptoms in older adult = test anti-IgLON5 antibodies.

• Medical treatment. IVIG (best evidence if started early within first year); rituximab; corticosteroids; plasma exchange.

• Natural/lifestyle treatment. Fall prevention; CPAP for sleep apnea; swallowing therapy.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Progressive disability, respiratory failure (stridor/central hypoventilation), death (19-34% mortality).

• Harms to others. None directly.

• Can it be overcome? Early immunotherapy associated with better outcomes; delayed treatment leads to irreversible neurodegeneration.

95. MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease)

• What it is. Distinct from both MS and NMOSD; anti-MOG antibodies attack myelin.

• Clinical presentation. Optic neuritis (often bilateral, severe but recoverable), transverse myelitis, ADEM, brainstem encephalitis, cortical encephalitis with seizures.

• How to diagnose. Anti-MOG antibodies (cell-based assay, NOT ELISA), MRI brain/spine, CSF analysis.

• Common misdiagnoses. Multiple sclerosis (most common misdiagnosis), NMOSD, ADEM (in children), CNS lymphoma, neurosarcoidosis.

• How to prevent diagnostic errors. Bilateral optic neuritis or ADEM-like presentation should prompt MOG antibody testing; MS treatments may be ineffective or harmful.

• Medical treatment. Acute: IV methylprednisolone, IVIG, plasma exchange; maintenance: IVIG, mycophenolate, azathioprine, rituximab; prolonged steroid taper.

• Natural/lifestyle treatment. Stress management; rehabilitation; vision therapy.

• Drugs that worsen. Fingolimod and natalizumab (MS drugs, may be ineffective or worsen); interferon-beta (may worsen).

• Food effects. No specific food effects.

• Harms to self. Vision loss (usually recoverable), paraplegia, cognitive impairment.

• Harms to others. None directly.

• Can it be overcome? Better visual recovery than NMOSD; relapsing course in ~50% of adults; monophasic in many children.

96. Autoimmune Pulmonary Alveolar Proteinosis

• What it is. Autoantibodies against GM-CSF impair alveolar macrophage function; more common in men (2:1).

• Clinical presentation. Progressive dyspnea, cough (usually dry), fatigue; crazy paving pattern on CT; increased risk of opportunistic infections.

• How to diagnose. Anti-GM-CSF antibodies (serum), CT chest (crazy paving), BAL (milky fluid with PAS-positive material).

• Common misdiagnoses. Pneumocystis pneumonia, pulmonary edema, lipoid pneumonia, alveolar hemorrhage, sarcoidosis.

• How to prevent diagnostic errors. Crazy paving on CT + anti-GM-CSF antibodies = autoimmune PAP; check GM-CSF antibodies before assuming infection.

• Medical treatment. Whole lung lavage (gold standard); inhaled GM-CSF (recombinant); rituximab; plasmapheresis.

• Natural/lifestyle treatment. Smoking cessation; avoid dust exposure; infection prevention.

• Drugs that worsen. Immunosuppressants (worsen PAP by further suppressing macrophage function).

• Food effects. No specific food effects.

• Harms to self. Respiratory failure, opportunistic infections, pulmonary fibrosis (rare).

• Harms to others. None directly.

• Can it be overcome? Whole lung lavage is highly effective; inhaled GM-CSF shows promise; some achieve spontaneous remission.

97. Autoimmune Lymphoproliferative Syndrome (ALPS)

• What it is. Defective Fas-mediated lymphocyte apoptosis (usually FAS gene mutations); autosomal dominant.

• Clinical presentation. Chronic non-malignant lymphadenopathy, splenomegaly (often massive), autoimmune cytopenias; increased lymphoma risk.

• How to diagnose. Elevated double-negative T cells (over 1.5% of lymphocytes), elevated biomarkers (B12, IL-10, IL-18), FAS gene sequencing.

• Common misdiagnoses. Lymphoma (most critical to exclude), Evans syndrome, CVID, SLE, Castleman disease.

• How to prevent diagnostic errors. Chronic lymphadenopathy + splenomegaly + autoimmune cytopenias = check double-negative T cells; exclude lymphoma.

• Medical treatment. Sirolimus/rapamycin (first-line); mycophenolate; corticosteroids for acute cytopenias; splenectomy avoided.

• Natural/lifestyle treatment. Infection prevention; cancer surveillance.

• Drugs that worsen. Corticosteroids (chronic use not recommended); splenectomy (high post-splenectomy sepsis risk).

• Food effects. No specific food effects.

• Harms to self. Lymphoma (lifetime risk ~10%), severe cytopenias, infections, splenic sequestration.

• Harms to others. Autosomal dominant (50% chance of passing to children).

• Can it be overcome? Sirolimus highly effective; lifelong lymphoma surveillance required.

98. Dressler Syndrome (Post-Cardiac Injury Syndrome)

• What it is. Autoimmune pericarditis occurring weeks to months after MI, cardiac surgery, or cardiac trauma.

• Clinical presentation. Pleuritic chest pain (sharp, worse with inspiration, relieved by sitting forward), fever, pericardial friction rub, effusions.

• How to diagnose. Clinical presentation + timing after cardiac injury, elevated CRP/ESR, echocardiogram, ECG, chest X-ray.

• Common misdiagnoses. Recurrent MI, pulmonary embolism, pneumonia, heart failure, aortic dissection.

• How to prevent diagnostic errors. Pleuritic chest pain + fever + pericardial effusion weeks after MI or cardiac surgery = Dressler syndrome.

• Medical treatment. NSAIDs (first-line); colchicine (reduces recurrence); corticosteroids (last resort); pericardiocentesis for tamponade.

• Natural/lifestyle treatment. Rest during acute phase; gradual return to activity.

• Drugs that worsen. Anticoagulants (increase risk of hemorrhagic pericardial effusion).

• Food effects. No specific food effects.

• Harms to self. Cardiac tamponade (rare), constrictive pericarditis (rare), recurrence (15-30%).

• Harms to others. None directly.

• Can it be overcome? Most resolve with NSAIDs + colchicine; recurrence common but usually self-limited.

99. Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS/McDuffie)

• What it is. Rare immune complex-mediated small-vessel vasculitis with anti-C1q antibodies, chronic urticaria, hypocomplementemia.

• Clinical presentation. Chronic urticaria lasting over 24 hours per lesion (burning more than itching), angioedema, arthralgia, glomerulonephritis, COPD-like obstructive lung disease.

• How to diagnose. Chronic urticaria over 6 months + hypocomplementemia (low C1q, C3, C4); minor criteria (vasculitis on biopsy, arthralgia, GN, uveitis); anti-C1q antibodies.

• Common misdiagnoses. Chronic spontaneous urticaria, SLE, cryoglobulinemia, Schnitzler syndrome, hereditary angioedema, serum sickness.

• How to prevent diagnostic errors. Urticaria lasting over 24 hours with residual bruising + low complement = biopsy for vasculitis.

• Medical treatment. Corticosteroids; hydroxychloroquine; dapsone; mycophenolate; cyclophosphamide; omalizumab; rituximab.

• Natural/lifestyle treatment. Avoid known triggers; stress management.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. COPD (leading cause of morbidity), renal failure, laryngeal edema (potentially fatal), blindness.

• Harms to others. None directly.

• Can it be overcome? Chronic course; significant morbidity from lung and kidney disease; no cure.

100. Psoriatic Arthritis

• What it is. Inflammatory arthritis associated with psoriasis; affects up to 30% of psoriasis patients; can occur without skin disease.

• Clinical presentation. Asymmetric oligoarthritis, symmetric polyarthritis, DIP-predominant, spondylitis, arthritis mutilans; dactylitis, enthesitis, nail changes.

• How to diagnose. CASPAR criteria (inflammatory arthritis + 3 points); MRI/ultrasound for enthesitis; X-ray (pencil-in-cup deformity).

• Common misdiagnoses. Rheumatoid arthritis, gout, osteoarthritis, reactive arthritis, ankylosing spondylitis.

• How to prevent diagnostic errors. DIP joint involvement + nail changes + dactylitis = PsA; RF usually negative; check hidden psoriasis (scalp, gluteal cleft).

• Medical treatment. NSAIDs; methotrexate; TNF inhibitors; IL-17 inhibitors (secukinumab, ixekizumab); IL-23 inhibitors; JAK inhibitors; apremilast.

• Natural/lifestyle treatment. Exercise; weight loss; Mediterranean diet; smoking cessation.

• Drugs that worsen. Lithium, beta-blockers, antimalarials (can worsen skin psoriasis).

• Food effects. Mediterranean diet and omega-3 help; alcohol worsens.

• Harms to self. Joint destruction (arthritis mutilans), cardiovascular disease, metabolic syndrome, depression.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Near-complete control possible with biologics; early treatment prevents joint damage.

101. Kawasaki Disease

• What it is. Acute febrile vasculitis of medium-sized arteries, primarily in children under 5; more common in boys.

• Clinical presentation. High fever over 5 days, bilateral conjunctival injection, oral changes (strawberry tongue), polymorphous rash, extremity changes, cervical lymphadenopathy.

• How to diagnose. Clinical criteria (fever + 4 of 5 features), echocardiogram (coronary aneurysms), elevated CRP/ESR, thrombocytosis.

• Common misdiagnoses. Scarlet fever, measles, adenovirus, Stevens-Johnson syndrome, JIA, toxic shock syndrome, drug reaction.

• How to prevent diagnostic errors. Incomplete Kawasaki (fewer than 4 criteria) is common and dangerous; any child with prolonged unexplained fever needs echocardiogram.

• Medical treatment. IVIG (2 g/kg within 10 days of fever onset) + high-dose aspirin; corticosteroids for high-risk; infliximab for IVIG-resistant.

• Natural/lifestyle treatment. Supportive care; cardiac follow-up.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Coronary artery aneurysms (leading cause of acquired pediatric heart disease), MI, death.

• Harms to others. None directly.

• Can it be overcome? Excellent prognosis with timely IVIG (reduces aneurysm risk from 25% to 5%).

102. IgA Vasculitis (Henoch-Schonlein Purpura)

• What it is. IgA-mediated small-vessel vasculitis; most common vasculitis in children; more severe in adults.

• Clinical presentation. Palpable purpura (legs and buttocks), arthritis/arthralgia, abdominal pain (colicky, GI bleeding), nephritis; scrotal involvement in boys/men.

• How to diagnose. Clinical presentation (palpable purpura + arthritis/abdominal pain/nephritis), skin biopsy (leukocytoclastic vasculitis with IgA), urinalysis.

• Common misdiagnoses. ITP, meningococcemia, drug-induced vasculitis, hypersensitivity vasculitis, SLE, polyarteritis nodosa.

• How to prevent diagnostic errors. Palpable purpura + abdominal pain + arthritis + hematuria = IgA vasculitis; platelet count is NORMAL (unlike ITP).

• Medical treatment. Supportive care (most cases self-limited); NSAIDs for arthritis; corticosteroids for severe GI/renal; mycophenolate/cyclophosphamide for severe nephritis.

• Natural/lifestyle treatment. Rest; adequate hydration; monitor urine for 6 months.

• Drugs that worsen. NSAIDs (use cautiously with renal involvement).

• Food effects. No specific food effects.

• Harms to self. Renal failure (1-5% of children, higher in adults), GI hemorrhage, intussusception, CKD.

• Harms to others. None directly.

• Can it be overcome? Self-limited in most children (weeks); adults have worse renal prognosis.

103. Autoimmune Enteropathy (Adult-Onset)

• What it is. Severe immune-mediated villous atrophy of small bowel; distinct from celiac disease (not gluten-responsive).

• Clinical presentation. Severe chronic diarrhea, malabsorption, weight loss, protein-losing enteropathy; does NOT respond to gluten-free diet.

• How to diagnose. Anti-enterocyte antibodies, anti-goblet cell antibodies, small bowel biopsy (villous atrophy), negative celiac serology, no GFD response.

• Common misdiagnoses. Celiac disease (most common misdiagnosis), tropical sprue, CVID-associated enteropathy, Crohn's, Whipple, intestinal lymphoma.

• How to prevent diagnostic errors. Villous atrophy NOT responding to gluten-free diet + anti-enterocyte antibodies = autoimmune enteropathy; check Ig levels for CVID.

• Medical treatment. Corticosteroids; azathioprine; tacrolimus; sirolimus; infliximab; IVIG; nutritional support (often TPN).

• Natural/lifestyle treatment. Nutritional rehabilitation; small frequent meals; vitamin supplementation.

• Drugs that worsen. None specific.

• Food effects. No specific food effects (unlike celiac, GFD does not help).

• Harms to self. Severe malnutrition, micronutrient deficiencies, infections, death if untreated.

• Harms to others. None directly.

• Can it be overcome? Variable; some respond well to immunosuppression; refractory cases may require long-term TPN.

104. Acute Rheumatic Fever

• What it is. Post-streptococcal autoimmune inflammatory disease; molecular mimicry between strep M protein and cardiac/joint/brain tissue.

• Clinical presentation. Jones criteria: carditis (pancarditis, valvular), migratory polyarthritis, Sydenham chorea, erythema marginatum, subcutaneous nodules; fever.

• How to diagnose. Modified Jones criteria (2015 AHA): evidence of preceding strep infection (ASO/anti-DNase B) + 2 major or 1 major + 2 minor.

• Common misdiagnoses. JIA, reactive arthritis, infective endocarditis, SLE, leukemia, viral myocarditis.

• How to prevent diagnostic errors. Migratory arthritis + recent strep infection = ARF; echocardiogram can detect subclinical carditis.

• Medical treatment. Aspirin/NSAIDs (arthritis); corticosteroids (severe carditis); penicillin (acute); secondary prophylaxis with monthly IM benzathine penicillin.

• Natural/lifestyle treatment. Adequate treatment of strep pharyngitis (primary prevention); dental hygiene.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Rheumatic heart disease (mitral stenosis, aortic regurgitation), heart failure, stroke, death.

• Harms to others. Strep is contagious.

• Can it be overcome? Arthritis resolves completely; carditis can cause permanent valvular damage; prophylaxis prevents recurrence.

105. Latent Autoimmune Diabetes in Adults (LADA)

• What it is. Slowly progressive autoimmune destruction of beta cells in adults; shares features of both T1D and T2D.

• Clinical presentation. Diagnosed as type 2 diabetes but lean, poor response to oral medications, progressive insulin requirement.

• How to diagnose. GAD65 antibodies (most sensitive), IA-2 antibodies, ZnT8 antibodies, C-peptide (initially normal, progressively declining).

• Common misdiagnoses. Type 2 diabetes (most common misdiagnosis), maturity-onset diabetes of the young (MODY).

• How to prevent diagnostic errors. Lean adult with type 2 diabetes failing oral medications = check GAD65 antibodies; early insulin preserves beta cell function.

• Medical treatment. Early insulin (preserves beta cell function); DPP-4 inhibitors may help; sulfonylureas AVOIDED; metformin adjunctively.

• Natural/lifestyle treatment. Exercise; healthy diet; weight management; stress reduction.

• Drugs that worsen. Sulfonylureas (accelerate beta cell destruction); thiazolidinediones (limited benefit).

• Food effects. Low glycemic index diet helps.

• Harms to self. Retinopathy, nephropathy, neuropathy, cardiovascular disease.

• Harms to others. Genetic susceptibility.

• Can it be overcome? Not curable; progresses to insulin dependence; early insulin may slow progression.

106. Bickerstaff Brainstem Encephalitis

• What it is. Autoimmune brainstem encephalitis; overlaps with Miller Fisher syndrome and GBS; anti-GQ1b antibodies; often post-infectious.

• Clinical presentation. Altered consciousness, bilateral ophthalmoplegia, ataxia, hyperreflexia (unlike GBS which has areflexia), facial weakness, bulbar palsy.

• How to diagnose. Anti-GQ1b antibodies (~65%), MRI brain (brainstem enhancement), CSF (elevated protein), EEG (diffuse slowing).

• Common misdiagnoses. Brainstem stroke, Wernicke encephalopathy, Listeria rhombencephalitis, MS, brainstem tumor, viral encephalitis.

• How to prevent diagnostic errors. Ophthalmoplegia + ataxia + altered consciousness after infection = Bickerstaff; hyperreflexia distinguishes from GBS.

• Medical treatment. IVIG or plasmapheresis (same as GBS); corticosteroids (may help); supportive ICU care.

• Natural/lifestyle treatment. Rehabilitation; physical therapy; occupational therapy.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Respiratory failure, prolonged coma, residual neurological deficits.

• Harms to others. None directly.

• Can it be overcome? Most recover well; some have residual deficits; relapses rare.

107. Autoimmune GFAP Astrocytopathy

• What it is. Autoimmune CNS disease with antibodies against glial fibrillary acidic protein (GFAP); 55% male; 18-24% paraneoplastic.

• Clinical presentation. Subacute meningoencephalomyelitis: headache, fever, encephalopathy, cerebellar dysfunction, myelitis, visual symptoms, tremor, seizures.

• How to diagnose. GFAP-IgG in CSF (gold standard), MRI brain (linear perivascular radial enhancement perpendicular to ventricles, pathognomonic), MRI spine.

• Common misdiagnoses. Tuberculous meningitis, viral meningoencephalitis, CNS lymphoma, neurosarcoidosis, MS, NMOSD, ADEM.

• How to prevent diagnostic errors. Linear perivascular radial enhancement perpendicular to ventricles on MRI is nearly pathognomonic; if anti-infective treatment fails, test CSF for GFAP-IgG.

• Medical treatment. Corticosteroids (first-line, 83% achieve remission); IVIG; rituximab; treat underlying tumor; long-term immunosuppression for relapsing cases.

• Natural/lifestyle treatment. Rehabilitation; physical therapy; cognitive rehabilitation.

• Drugs that worsen. None specific.

• Food effects. No specific food effects.

• Harms to self. Relapse in ~20% despite treatment; residual cognitive and motor deficits; death in severe cases.

• Harms to others. None directly.

• Can it be overcome? Majority have monophasic course with good outcome; relapsing course in minority; early steroid treatment is key.

The 15 Diagnostic Confusion Clusters

These are the groups of autoimmune diseases that get mistaken for each other. Each entry includes the step-by-step approach to sort them out, the distinguishing features, and the critical pitfalls.

Cluster 1: Inflammatory Joint Diseases

• Diseases involved. RA, PsA, AS, Reactive Arthritis, Gout, OA

• Diagnostic algorithm. STEP 1: Inflammatory (morning stiffness >30 min, improves with activity) vs Mechanical (improves with rest). STEP 2: Symmetric small joints = RA. Asymmetric ray distribution + DIP = PsA. Axial + young man = AS. Asymmetric LE after infection = Reactive. Acute first MTP = Gout.

• Distinguishing features. RA: RF/anti-CCP+, symmetric, DIP spared. PsA: RF-, DIP involved, nail pitting. AS: HLA-B27+, axial, uveitis. Reactive: HLA-B27+, post-infection, conjunctivitis. Gout: tophi, podagra.

• Critical pitfalls. PsA can mimic RA when polyarticular. Check hidden psoriasis (scalp, gluteal cleft). Uric acid can elevate in psoriasis. AS delayed 7-10 years; inflammatory back pain IMPROVES with exercise.

Cluster 2: Autoimmune Liver Diseases

• Diseases involved. AIH, PBC, PSC

• Diagnostic algorithm. STEP 1: Hepatocellular (ALT/AST >> ALP) = AIH. Cholestatic (ALP >> ALT/AST) = PBC or PSC. STEP 2: AMA+ = PBC. MRCP shows beading = PSC. Steroid-responsive = AIH.

• Distinguishing features. AIH: F>M, any age, ANA+SMA, elevated IgG, responds to steroids. PBC: F>>M, AMA+, elevated IgM, ALP elevated. PSC: M>F (7:3), pANCA+, MRCP beading, 80% have UC.

• Critical pitfalls. PSC PREFERS men. Any man with UC + elevated ALP needs MRCP. AIH in men often blamed on alcohol or fatty liver. Steroid response: AIH responds, PBC/PSC do not.

Cluster 3: Demyelinating CNS Diseases

• Diseases involved. MS, NMOSD, MOGAD, GFAP Astrocytopathy

• Diagnostic algorithm. MS: relapsing, lesions disseminated in time/space, central vein sign on MRI. NMOSD: severe bilateral ON + longitudinally extensive myelitis, AQP4+. MOGAD: bilateral ON with good recovery, ADEM-like. GFAP: subacute meningoencephalomyelitis with linear perivascular radial enhancement.

• Distinguishing features. MS: oligoclonal bands present, AQP4-, MOG-. NMOSD: AQP4+ in 70%, lesions ≥3 vertebral segments. MOGAD: MOG+ (cell-based assay, NOT ELISA). GFAP: GFAP-IgG in CSF, characteristic MRI pattern.

• Critical pitfalls. MS drugs (interferon, fingolimod, natalizumab) WORSEN NMOSD. Test AQP4 before starting MS therapy. Central vein sign favors MS over NMOSD. GFAP often misdiagnosed as infectious meningitis.

Cluster 4: Autoimmune Cytopenias

• Diseases involved. AIHA, ITP, TTP, Evans Syndrome, Cold Agglutinin Disease

• Diagnostic algorithm. STEP 1: What is low? RBCs only = AIHA or CAD. Platelets only = ITP or TTP. Both = Evans or TTP. STEP 2: Hemolysis present? Yes = AIHA/TTP/Evans. No = ITP. STEP 3: Schistocytes = TTP (emergency).

• Distinguishing features. AIHA: positive Coombs (warm IgG or cold IgM/C3d). ITP: isolated low platelets, normal smear. TTP: schistocytes, ADAMTS13 <10%. Evans: ≥2 autoimmune cytopenias, positive Coombs + low platelets. CAD: C3d+/IgG-, cold agglutinin titer high.

• Critical pitfalls. TTP is a medical emergency: thrombocytopenia + MAHA + neuro symptoms = start plasma exchange before results return. Do NOT transfuse platelets in TTP. DAT-negative AIHA in 3-10%. Evans needs underlying SLE/ALPS/lymphoma workup.

Cluster 5: Autoimmune Thyroid Diseases

• Diseases involved. Graves' Disease, Hashimoto's, Hashitoxicosis

• Diagnostic algorithm. STEP 1: Hyperthyroid (low TSH, high T4/T3) = Graves' or Hashitoxicosis. Hypothyroid (high TSH, low T4) = Hashimoto's. STEP 2: TRAb+ = Graves'. TRAb- with low RAIU = Hashitoxicosis.

• Distinguishing features. Graves': TRAb+ (97.7% sens, 99.5% spec), high RAIU, ophthalmopathy. Hashitoxicosis: TPO+, low RAIU, self-limited. Hashimoto's: TPO+, high TSH, low T4.

• Critical pitfalls. In men, Graves' symptoms blamed on stress. Always check TSH in new AF, anxiety, weight loss. Don't treat Hashitoxicosis with methimazole - it accelerates hypothyroidism. Biotin supplements cause falsely low TSH.

Cluster 6: Autoimmune Blistering Diseases

• Diseases involved. Pemphigus Vulgaris/Foliaceus, Bullous Pemphigoid, MMP, Dermatitis Herpetiformis, Linear IgA, EBA

• Diagnostic algorithm. STEP 1: Intraepidermal (flaccid blisters, Nikolsky+) = Pemphigus. Subepidermal (tense blisters) = Pemphigoid/EBA/DH/Linear IgA. STEP 2: DIF pattern is diagnostic.

• Distinguishing features. PV: intercellular IgG (chicken wire), oral involvement, Dsg3+/Dsg1+. PF: intercellular IgG superficial, no mucosa, Dsg1+ only. BP: linear IgG/C3 at DEJ, tense blisters, intense itch, elderly. DH: granular IgA in dermal papillae, celiac association. Linear IgA: linear IgA at DEJ, drug-induced (vancomycin). EBA: linear IgG at DEJ, dermal binding on salt-split skin.

• Critical pitfalls. Take perilesional biopsy (not blister) for DIF. PV often presents with oral erosions FIRST. BP can present without blisters (urticarial phase). DH = skin celiac disease. Drug-induced Linear IgA resolves after stopping drug.

Cluster 7: ANCA-Associated Vasculitides

• Diseases involved. GPA, MPA, EGPA

• Diagnostic algorithm. STEP 1: ANCA pattern. c-ANCA/PR3 = GPA. p-ANCA/MPO = MPA or EGPA. STEP 2: Clinical features. Upper airway destruction = GPA. Asthma + eosinophilia = EGPA. Pulmonary-renal without granulomas = MPA.

• Distinguishing features. GPA: c-ANCA/PR3 (~90%), upper airway + lung + kidney, granulomas. MPA: p-ANCA/MPO (~90%), pulmonary-renal, no granulomas. EGPA: p-ANCA/MPO in ~40%, asthma + eosinophilia (>1500), eosinophilic granulomas.

• Critical pitfalls. GPA presents as chronic sinusitis for years. PAN is ANCA-NEGATIVE (testicular pain is a clue in men). EGPA: any asthmatic developing neuropathy or purpura. 10% of AAV is ANCA-negative; biopsy is essential.

Cluster 8: Neuromuscular Junction Disorders

• Diseases involved. Myasthenia Gravis, Lambert-Eaton Syndrome

• Diagnostic algorithm. STEP 1: Direction of weakness. Cranial first (ptosis, diplopia) = MG. Proximal legs first = LEMS. STEP 2: Reflexes. Normal = MG. Diminished but improve after exercise = LEMS.

• Distinguishing features. MG: AChR+ (85%), MuSK+ (5%), thymoma (20%), decrement on 3 Hz RNS. LEMS: VGCC+ (>90%), SCLC (50-60%), low CMAPs, increment >100% post-exercise.

• Critical pitfalls. LEMS can mimic myopathy. Diminished reflexes that improve after exercise = LEMS pathognomonic. 50-60% of LEMS has SCLC; mandatory cancer screening. MuSK-MG has prominent bulbar weakness and poor pyridostigmine response.

Cluster 9: Connective Tissue Diseases

• Diseases involved. SLE, Sjogren's, Scleroderma, MCTD, DM/PM

• Diagnostic algorithm. ANA+ is the gateway. PATTERN and SPECIFIC antibodies determine diagnosis. Anti-dsDNA/Smith = SLE. Anti-SSA/SSB = Sjogren's. Anti-Scl-70/centromere = Scleroderma. Anti-U1 RNP high titer = MCTD. CK + skin rash = DM.

• Distinguishing features. SLE: low complement, anti-dsDNA, multi-organ. Sjogren's: anti-SSA, dry eyes/mouth, salivary gland biopsy. Scleroderma: skin thickening, Raynaud's, nailfold capillary changes. MCTD: anti-U1 RNP + overlap features. DM/PM: elevated CK, characteristic skin findings.

• Critical pitfalls. SLE in men is missed because doctors don't think of it. Sjogren's RF+ in 50% leads to RA misdiagnosis. DM in men >40 = mandatory cancer screening. Scleroderma renal crisis: ACE inhibitors are lifesaving, NOT steroids.

Cluster 10: Autoimmune Endocrine Diseases

• Diseases involved. T1D, LADA, Addison's, Hypoparathyroidism, Hypophysitis

• Diagnostic algorithm. LADA trap: lean adult with type 2 diabetes failing oral meds = check GAD65. Sulfonylureas accelerate beta cell loss in LADA. Addison's: hyperpigmentation + hyponatremia + hyperkalemia is near-pathognomonic.

• Distinguishing features. T1D: autoantibodies (GAD65, IA-2, ZnT8), low C-peptide, lean, ketosis common. LADA: GAD65+ but initially insulin-independent, age >30, lean. Addison's: morning cortisol low, ACTH high, hyperpigmentation (74%). Hypoparathyroidism: low Ca, high P, low PTH. Hypophysitis: multiple pituitary hormone deficiencies, MRI symmetric enlargement.

• Critical pitfalls. Addison's misdiagnosed as depression/CFS for 1-2 years. Hyperpigmentation is MOST specific clue. Adrenal crisis: give IV hydrocortisone 100 mg immediately. Start hydrocortisone BEFORE levothyroxine in hypophysitis.

Cluster 11: Inflammatory Myopathies

• Diseases involved. DM, PM, IBM, IMNM, Antisynthetase Syndrome

• Diagnostic algorithm. Pattern of weakness + CK level + antibodies. DM: symmetric proximal + skin rash. IBM: asymmetric quadriceps + finger flexors (pathognomonic). IMNM: very high CK + rapid onset. Antisynthetase: ILD + mechanic's hands + Raynaud's.

• Distinguishing features. DM: anti-TIF1g (cancer), anti-NXP2 (cancer), anti-MDA5 (severe ILD, low cancer risk), heliotrope rash. IBM: anti-cN1A, mildly elevated CK, rimmed vacuoles. IMNM: anti-HMGCR (statin-triggered), anti-SRP, very high CK. Antisynthetase: anti-Jo-1 most common.

• Critical pitfalls. DM in men >40 = mandatory cancer screening. IBM frequently misdiagnosed as treatment-resistant polymyositis. Statin-triggered IMNM PERSISTS after stopping statin (unlike simple statin myopathy). Polymyositis is increasingly a diagnosis of exclusion.

Cluster 12: Autoimmune Encephalitides

• Diseases involved. NMDAR, LGI1, CASPR2, Anti-IgLON5, GFAP Astrocytopathy

• Diagnostic algorithm. Age + sex + tempo distinguish. Young + psychiatric + dyskinesias = NMDAR. Older man + FBDS + hyponatremia = LGI1. Older man + neuromyotonia + sleep + autonomic = CASPR2. Progressive sleep + bulbar = IgLON5. Subacute meningoencephalitis + radial MRI = GFAP.

• Distinguishing features. NMDAR: serum + CSF (CSF more sensitive). LGI1: serum more sensitive, hyponatremia. CASPR2: peripheral nerve hyperexcitability, Morvan syndrome with thymoma. IgLON5: HLA-DRB1*10:01, brainstem tauopathy. GFAP: CSF GFAP-IgG, perivascular radial MRI enhancement.

• Critical pitfalls. NMDAR in men misdiagnosed as schizophrenia. LGI1 misdiagnosed as dementia (progresses over weeks, not years). CASPR2-Morvan syndrome can mimic CJD. IgLON5 frequently unknown, treat early with IVIG. 45% of GFAP cases have coexisting antibodies.

Cluster 13: IgG4-RD vs Mimics

• Diseases involved. IgG4-RD vs Lymphoma, Pancreatic Cancer, Sarcoidosis, Sjogren's, GPA

• Diagnostic algorithm. Painless multi-organ mass lesions in older man = consider IgG4-RD. BIOPSY IS ESSENTIAL (storiform fibrosis + obliterative phlebitis + IgG4/IgG >40%). Elevated IgG4 alone is NOT diagnostic.

• Distinguishing features. IgG4-RD: storiform fibrosis, IgG4+ plasma cells, normal LDH, low C3, dramatic steroid response. Lymphoma: B symptoms, elevated LDH, anemia, large lymphadenopathy. Pancreatic cancer: focal mass, abrupt duct cutoff, no other organ involvement. Sarcoidosis: non-necrotizing granulomas.

• Critical pitfalls. Elevated IgG4 occurs in 4-7% of pancreatic cancers. Multi-organ involvement favors IgG4-RD over cancer. Steroid trial only after excluding malignancy (lymphoma can transiently respond too). Excisional biopsy preferred for lymphadenopathy.

Cluster 14: Sarcoidosis vs Mimics

• Diseases involved. Sarcoidosis vs TB, Lymphoma, Berylliosis

• Diagnostic algorithm. Bilateral hilar LAD = always biopsy (even if 'classic'). Non-necrotizing granulomas + exclusion of TB/fungal/lymphoma = sarcoidosis. Löfgren syndrome (uveitis + erythema nodosum + bilateral hilar LAD) is virtually diagnostic.

• Distinguishing features. Sarcoidosis: non-necrotizing granulomas, hypercalcemia (10-15%), anergy on PPD, high CD4/CD8 in BAL (>3.5). TB: necrotizing (caseating) granulomas, AFB+, often unilateral. Lymphoma: B symptoms, no granulomas. Berylliosis: occupational exposure, positive BeLPT.

• Critical pitfalls. ACE level is neither sensitive nor specific. Always rule out TB before starting immunosuppression (steroids can reactivate latent TB). Lymphoma can cause sarcoid-like reaction; rebiopsy if atypical features.

Cluster 15: Autoimmune Kidney Diseases

• Diseases involved. IgA Nephropathy, Membranous, Goodpasture, Lupus Nephritis, C3 Glomerulopathy, ANCA-GN

• Diagnostic algorithm. Clinical: nephritic vs nephrotic vs RPGN. Then serology and biopsy IF pattern. LINEAR IgG = Goodpasture (emergency). Pauci-immune = ANCA-GN. Full house = lupus. Dominant IgA = IgA nephropathy. C3 dominant = C3G. Anti-PLA2R+ = primary membranous.

• Distinguishing features. IgA: IgA dominant on IF, synpharyngitic hematuria. Membranous: anti-PLA2R+ (70-80%), subepithelial deposits, spike and dome. Goodpasture: linear IgG, anti-GBM+, hemoptysis. Lupus: full house IF, anti-dsDNA+, low complement. C3G: dominant C3 no Ig, low C3 normal C4. ANCA-GN: ANCA+, pauci-immune, crescents.

• Critical pitfalls. Goodpasture + ANCA overlap in ~30%; always check both. IgA nephropathy = synpharyngitic (within 1-2 days of URI); post-strep GN = 1-3 weeks later. Membranous in men >50 = cancer screening mandatory. Lupus nephritis can transform between classes.

Cancer Screening Protocols

Several autoimmune diseases — particularly the paraneoplastic ones — carry a real risk that an undiagnosed cancer is the actual cause. These are the screening protocols.

Inflammatory Myopathies — IMACS 2023 Risk Stratification

• Risk stratification / antibody map. HIGH RISK (~20% cancer in 3 years): DM with anti-TIF1g, DM with anti-NXP2, DM with anti-SAE1, any IIM with age >40 + male + dysphagia + cutaneous ulceration. INTERMEDIATE: PM, IMNM (especially seronegative), amyopathic DM without high-risk antibodies. STANDARD: antisynthetase, overlap myositis, IBM.

• Imaging and test protocol. HIGH: Enhanced screening + PET/CT if negative. INTERMEDIATE: CT chest/abdomen/pelvis + tumor markers + endoscopy. STANDARD: Age/sex-appropriate. ALL: CBC, CMP, urinalysis, CXR, stool occult blood.

• Timing and frequency. Initial: at diagnosis. Repeat: every 6-12 months for first 3 years. After 3 years: age-appropriate. Refractory myositis: re-screen for occult malignancy.

• Associated cancers / notes. Lung, colorectal, prostate, bladder, nasopharyngeal, lymphoma, pancreatic. Male sex independently increases risk (RR 1.53).

Myasthenia Gravis — Thymoma Screening

• Risk stratification / antibody map. ALL newly diagnosed MG patients. Striational antibodies (anti-titin, anti-ryanodine) in patients under 45 highly predictive of thymoma.

• Imaging and test protocol. CT or MRI of chest (mediastinum) at diagnosis. Sensitivity ~90%, specificity ~95%.

• Timing and frequency. If thymoma detected: thymectomy. Post-thymectomy: chest CT every 6-12 months for 2 years, then annually for up to 10 years (thymoma) or 5 years (thymic carcinoma).

• Associated cancers / notes. Thymoma in 10-20% of MG patients. Older age at MG onset and thymoma presence increase risk of extrathymic malignancies.

Lambert-Eaton Syndrome — SCLC Screening

• Risk stratification / antibody map. DELTA-P Score: Smoking (+3 current/+1 former), age ≥50 (+1), weight loss ≥5% (+1), bulbar involvement (+1), ED/male (+1), KPS ≤70 (+1). Score 0 = 0% risk; Score 6 = 100% risk. SOX2/N-VGCC/GABAb antibodies = sensitivity 84%, specificity 87% for SCLC.

• Imaging and test protocol. CT thorax at diagnosis (detects 83-93%). If negative: FDG-PET/CT. If both negative: repeat CT at 3-6 months.

• Timing and frequency. Continue screening every 6 months for 2 years (96% of SCLCs found within 1 year).

• Associated cancers / notes. Small-cell lung cancer in 50-60% of LEMS. ALL SCLC patients had positive smoking history.

Paraneoplastic Neurological Syndromes — Antibody Map

• Risk stratification / antibody map. HIGH cancer risk (>70%): anti-Hu/ANNA-1 (SCLC 88%), anti-Yo/PCA-1 (ovarian, breast), anti-Ri/ANNA-2 (breast, SCLC), anti-CV2/CRMP5 (SCLC, thymoma), anti-amphiphysin (breast/SCLC), anti-Ma2 (testicular GCT in young men, SCLC in older), anti-KLHL11 (testicular seminoma), anti-SOX1 (SCLC). INTERMEDIATE: P/Q-type VGCC (SCLC), anti-NMDAR (ovarian teratoma in women, rare in men), anti-CASPR2 (thymoma 20%). LOW: anti-GAD65, anti-LGI1.

• Imaging and test protocol. Send comprehensive PNS antibody panel (serum AND CSF). Image based on antibody: anti-Hu/SOX1/VGCC = CT chest → FDG-PET. Anti-Yo = CT/MRI pelvis + mammography. Anti-Ma2 young men = testicular ultrasound (consider biopsy if microcalcifications). Anti-CASPR2 = CT mediastinum. Anti-NMDAR in men = CT chest/abdomen/pelvis.

• Timing and frequency. If initial negative but suspicion high: repeat at 3-6 months for at least 2 years. FDG-PET/CT sensitivity 81%, specificity 88%. Ovarian teratomas don't take up FDG (use ultrasound/MRI). Microscopic testicular tumors invisible on imaging.

• Associated cancers / notes. Tumor markers NOT recommended for screening. Onconeural antibodies don't screen for cancer in absence of neurological syndrome. PNS-CARE 2021 criteria: sensitivity 93%, specificity 100%.

Paraneoplastic Pemphigus

• Risk stratification / antibody map. Nearly 100% have underlying neoplasm. NHL most common (38%), CLL (18%), Castleman (especially children/young adults/Asian populations), thymoma (6%), sarcomas, Waldenström.

• Imaging and test protocol. CBC with differential and smear, SPEP and immunofixation, CT chest/abdomen/pelvis, FDG-PET/CT if CT negative, bone marrow biopsy, flow cytometry.

• Timing and frequency. At diagnosis and follow-up.

• Associated cancers / notes. Bronchiolitis obliterans (6-70%) is leading cause of death; mortality ~90% at 2 years.

Membranous Nephropathy

• Risk stratification / antibody map. Cancer in ~10% within 1 year. Lung, colon, prostate, stomach, kidney, breast. Anti-PLA2R-negative MN has higher cancer risk.

• Imaging and test protocol. Age/sex-appropriate cancer screening, CXR or CT, iron studies, PSA in men >50-60, national screening programs. FDG-PET/CT detected cancer in 10.2% vs 1.3% with conventional screening.

• Timing and frequency. At diagnosis. Re-screen if refractory or relapsing.

• Associated cancers / notes. Anti-THSD7A and anti-NELL1 antibodies may also be associated with malignancy.

Other Autoimmune-Cancer Associations

• Risk stratification / antibody map. Systemic sclerosis: lung cancer, breast cancer (anti-RNA pol III within 3 years). Sjogren's: NHL (5-10% lifetime, 15-20x general population). SLE: NHL, lung cancer. AIH with cirrhosis: HCC. PSC: cholangiocarcinoma (10-15% lifetime), colorectal (if UC). Celiac: enteropathy-associated T-cell lymphoma. VEXAS: MDS, MPN. Multicentric Castleman: lymphoma transformation.

• Imaging and test protocol. Disease-specific: scleroderma → CT chest if anti-RNA pol III+; Sjogren's → monitor parotid swelling, monoclonal gammopathy; AIH cirrhosis → US + AFP every 6 months; PSC → annual MRCP + CA 19-9, colonoscopy if UC; celiac → suspect EATL if refractory; VEXAS → bone marrow biopsy at diagnosis.

• Timing and frequency. Lifetime surveillance for high-risk associations.

• Associated cancers / notes. Heightened awareness for any unusual symptoms in these patients.

5 Rules of Paraneoplastic Cancer Screening

• Risk stratification / antibody map. 1. THINK PARANEOPLASTIC when autoimmune disease presents atypically, at unusual age, with rapid onset, or refractory to treatment. 2. SEND THE FULL PANEL — comprehensive paraneoplastic antibodies, not individual tests. 3. IMAGE BASED ON THE ANTIBODY — antibody tells you where to look. 4. REPEAT IF NEGATIVE — if initial screening negative but suspicion high, repeat at 3-6 months for at least 2 years. 5. TREAT THE CANCER — in true paraneoplastic disease, treating the cancer is the most effective treatment for the autoimmune condition.

• Imaging and test protocol. Tier 1: CT chest/abdomen/pelvis + organ-specific imaging. Tier 2: FDG-PET/CT (skull base to mid-thigh) if Tier 1 negative. Tier 3: repeat imaging every 3-6 months for at least 2 years; consider biopsy of suspicious areas.

• Timing and frequency. Refractoriness to immunosuppression should ALWAYS prompt re-screening for occult malignancy.

• Associated cancers / notes. The autoimmune disease can be the smoke; the cancer is the fire. Treating the smoke without finding the fire is futile.